Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
   volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             2253 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 AçaÍ (Euterpe oleraceae Mart) berry extract protects neuronal cells against beta-amyloid toxicity and inhibits beta-amyloid fibril formation in vitro Wong, Daphne
2013
9 4S p. P808
artikel
2 AAIC 2013 Scientific Program Committee 2013
9 4S p. A1
artikel
3 Aberrant calcium signaling modulates inflammatory and PI3/Akt pathways in Alzheimer's disease Afanador, Lauriasella
2013
9 4S p. P352
artikel
4 Aberrant expression of the astrocyte glutamate transporter EAAT2 occurs in early-stage Alzheimer's disease and precedes hippocampal synaptic loss Meabon, James
2013
9 4S p. P191
artikel
5 Aberrant tau and amyloid pathology underlie 1H MR spectroscopic alterations in Alzheimer's disease and Lewy body disease Murray, Melissa
2013
9 4S p. P391
artikel
6 Aberrant tau and amyloid pathology underlies 1H MR spectroscopic alterations in Alzheimer's disease and Lewy body disease Murray, Melissa
2013
9 4S p. P43
artikel
7 A bioenergetic trajectory of female brain aging and Alzheimer's disease 3: Development of metabolic and physiological biomarker profiles for early detection of women at risk for Alzheimer's disease Rettberg, Jamaica
2013
9 4S p. P348-P349
artikel
8 A bioenergetic trajectory of female brain aging and Alzheimer's disease 1: Implications for risk prevention and treatment Zhao, Liqin
2013
9 4S p. P349
artikel
9 A bioenergetic trajectory of female brain aging and Alzheimer's disease 2: Mechanistic link between mitochondrial dysfunction and white matter degeneration in the normal mammalian aging female brain Klosinski, Lauren
2013
9 4S p. P348
artikel
10 Ablation of striatal dopamine exacerbates cognitive impairment in a mouse model of Alzheimer's disease Melief, Erica
2013
9 4S p. P188
artikel
11 Abnormal cerebral blood flow exacerbates amyloid pathology in an Alzheimer's disease knock-in mice model Li, Hongmei
2013
9 4S p. P852
artikel
12 Abnormal hyperphosphorylation of tau and molecular mechanism of neurofibrillary degeneration Alonso, Alejandra
2013
9 4S p. P673-P674
artikel
13 Abnormalities of fronto-striato-thalamic tract structure and effective connectivity in familial Alzheimer's disease Kinnunen, Kirsi
2013
9 4S p. P43-P45
artikel
14 Abnormalities of fronto-striato-thalamic tract structure and effective connectivity in familial Alzheimer's disease Kinnunen, Kirsi
2013
9 4S p. P685-P687
artikel
15 A brain fitness program for people with dementia concurrent with a support group for their caregivers is feasible Neth, Bryan
2013
9 4S p. P647-P648
artikel
16 Academic achievement in High school English courses and risk of Alzheimer's disease and dementia: Findings from the Nun Study Tyas, Suzanne
2013
9 4S p. P621
artikel
17 A case of neurosyphilis with dementia and occipital lobe hypometabolism on 18FFDG-PET Kasanuki, Koji
2013
9 4S p. P745
artikel
18 A caspase-generated epitope of Tau measured in serum predicts progression of disease in early Alzheimer's disease patients Henriksen, Kim
2013
9 4S p. P127
artikel
19 Acceleration of cortical thinning in women with Alzheimer's disease Cho, Hanna
2013
9 4S p. P747-P748
artikel
20 Acceptance of social assistive robots to support older adults with cognitive impairment and their caregivers Pino, Maribel
2013
9 4S p. P342
artikel
21 Accordance to Dietary Approaches to Stop Hypertension (DASH) is associated with slower cognitive decline Tangney, Christy
2013
9 4S p. P135
artikel
22 Accuracy of executive function tests in predicting daily functioning in older people Faria, Camila
2013
9 4S p. P796
artikel
23 Accurate classification of early-stage Alzheimer's disease using a brief test of spatial memory Moodley, Kuven
2013
9 4S p. P766-P767
artikel
24 Acetyl-L-carnitine rescues scopolamine-induced memory deficits by restoring insulin-like growth factor II via decreasing p53 oxidation Xiang, Wang
2013
9 4S p. P159
artikel
25 A clinical phase II study of Lu AE58054 added to stable donepezil treatment in patients with moderate Alzheimer's disease Wilkinson, David
2013
9 4S p. P529
artikel
26 A coding mutation in APP protects against Alzheimer's disease and age-related cognitive decline Jonsson, Thorlakur
2013
9 4S p. P826-P827
artikel
27 A conceptual framework of subjective cognitive decline (SCD) in preclinical Alzheimer's disease (AD) Jessen, Frank
2013
9 4S p. P824
artikel
28 Activation of Nrf2-antioxidant signaling protects memory impairment in rats Dwivedi, Subhash
2013
9 4S p. P159
artikel
29 Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in a mouse model for Alzheimer's disease Martin, Paul
2013
9 4S p. P326-P327
artikel
30 Activities of daily living in MCI and its progression to dementia Shim, YongSoo
2013
9 4S p. P774
artikel
31 ACU-193: A candidate therapeutic antibody that selectively targets soluble beta-amyloid oligomers Krafft, Grant
2013
9 4S p. P326
artikel
32 Acute care and dementia: Emerging lessons from national policies Splaine, Michael
2013
9 4S p. P646-P647
artikel
33 Adcs electronic data capture: Collaborative development and management of clinical trial databases Jimenez-Maggiora, Gustavo
2013
9 4S p. P763-P764
artikel
34 ADCS electronic data capture: Integrated image management Jimenez-Maggiora, Gustavo
2013
9 4S p. P773
artikel
35 Addressing Koch's postulates: The role of herpes simplex virus in Alzheimer's disease Bearer, Elaine
2013
9 4S p. P116
artikel
36 ADGC+: An expanded Alzheimer's Disease Genetics Consortium (ADGC) genome-wide association study Martin, Eden
2013
9 4S p. P557
artikel
37 A DHA and EPA drink attenuates inflammation and improves beta-amyloid clearance in people with Alzheimer's disease Fiala, Milan
2013
9 4S p. P800
artikel
38 A diet rich in figs improves memory and learning in Alzheimer's disease transgenic (APPSw 2576) mice Essa, Mohamed
2013
9 4S p. P505-P506
artikel
39 A differential pattern of hippocampal atrophy in Alzheimer's disease with coexistent small-vessel disease: A multivariate shape-based analysis Nestor, Sean
2013
9 4S p. P33
artikel
40 A differential pattern of hippocampal atrophy in Alzheimer's disease with coexistent small vessel disease: A multivariate shape-based analysis Nestor, Sean
2013
9 4S p. P262
artikel
41 A diffusion-tensor imaging study of white matter microstructure in neurodegenerative disease Perea, Rodrigo
2013
9 4S p. P387
artikel
42 Adiposity indicators and brain structure Scarmeas, Nikolaos
2013
9 4S p. P836
artikel
43 Aerobic exercise effects on cognition in at-risk adults: Role of insulin sensitivity and APOE-ε4 Baker, Laura
2013
9 4S p. P690
artikel
44 Aerobic exercise-induced gene expression changes in aging individuals with mild cognitive impairment Iyalomhe, Osi
2013
9 4S p. P556
artikel
45 A first-in-human study of BAN2401, a novel monoclonal antibody against beta-amyloid protofibrils Lai, Robert
2013
9 4S p. P689
artikel
46 Aged beagle dogs demonstrate reduced brain metabolism measured using PET-MR Araujo, Joseph
2013
9 4S p. P851
artikel
47 Age-dependent accumulation of phosphorylated TDP-43 in an Alzheimer's disease mouse model Gitcho, Michael
2013
9 4S p. P721
artikel
48 Age-dependent default mode network functional connectivity in individuals with Down syndrome Vega, Jennifer
2013
9 4S p. P418
artikel
49 Age-dependent impairment of hilar GABAergic interneurons and cognitive function in Apolipoprotein E-ε4 knock-in mice is modified by sex Leung, Laura
2013
9 4S p. P357
artikel
50 Age, gender and education are associated with cognitive performance in among Israeli elderly individuals with type 2 diabetes Guerrero-Berroa, Elizabeth
2013
9 4S p. P796
artikel
51 A gene coexpression module in peripheral blood correlates with hippocampal atrophy in elderly individuals Apostolova, Liana
2013
9 4S p. P77
artikel
52 A gene co-expression module in peripheral blood correlates with hippocampal atrophy in elderly subjects Apostolova, Liana
2013
9 4S p. P201-P202
artikel
53 A general amyloid interaction motif (GAIM) approach to targeting multiple types of misfolded protein deposits in models of neurodegenerative disease Masliah, Eliezer
2013
9 4S p. P809
artikel
54 A genomewide association meta-analysis of plasma beta-amyloid peptide concentrations in the elderly Chouraki, Vincent
2013
9 4S p. P705-P706
artikel
55 Age-related frontal lobe compensation during novelty detection Chong, Catherine
2013
9 4S p. P398
artikel
56 Age-related microstructural alterations in deep gray matter: In vivo evidence from diffusional kurtosis imaging Gong, Nan-Jie
2013
9 4S p. P88
artikel
57 Age-specific incidence rates of Alzheimer's disease in family members participating in the NIA-LOAD genetics study Vardarajan, Badri
2013
9 4S p. P625-P626
artikel
58 Aggregation of vascular risk factors aggravates neuropsychological performance in mild cognitive impairment (MCI) independently of stroke disease Tay, Laura
2013
9 4S p. P768
artikel
59 A hypnic hypothesis of Alzheimer's disease Clark, Camilla
2013
9 4S p. P712
artikel
60 Akt-activated GSK3β inhibitory peptide effectively blocks tau phosphorylation Lee, Eunjin
2013
9 4S p. P890-P891
artikel
61 AKTIVA-MCI: First results of a new intervention program Tesky, Valentina
2013
9 4S p. P477
artikel
62 A linguistic validation and cultural adaptation of the ADAS-Cog and ADCS-ADL into Japanese, Korean and Mandarin Chinese Marsico, Mark
2013
9 4S p. P752-P753
artikel
63 A liposomal anti-phospho-tau vaccine demonstrates higher immunogenicity and specificity than a classical peptide vaccine approach Gafner, Valerie
2013
9 4S p. P326
artikel
64 Allopregnanolone as a regenerative therapeutic for Alzheimer's disease, 2: Bridging subcutaneous to intravenous formulations for clinical trials Irwin, Ronald
2013
9 4S p. P710-P711
artikel
65 Allopregnanolone as a regenerative therapeutic for Alzheimer's disease, 3: Evidence for potentiation of brain mitochondrial function Yao, Jia
2013
9 4S p. P709-P710
artikel
66 Allopregnanolone as a regenerative therapeutic for Alzheimer's disease, 1: From discovery to phase I multiple-ascending-dose clinical trial Brinton, Roberta
2013
9 4S p. P709
artikel
67 Allopregnanolone as a regenerative therapeutic for Alzheimer's disease, 4: Impact on neuronal versus gliosis phenotypic differentiation Chen, Shuhua
2013
9 4S p. P710
artikel
68 Alpha-synuclein oligomers can act as seed in a fibrillation assay but do not cause increased aggregation in living cells Ingelsson, Martin
2013
9 4S p. P721
artikel
69 Alpha-synuclein pathology in the medulla oblongata in association with the reduction of the ventilatory response to hypercapnia in dementia with Lewy bodies and Parkinson's disease Takahashi, Sho
2013
9 4S p. P435-P436
artikel
70 Alterations in metabolic pathways and networks in mild cognitive impairment and early Alzheimer's disease Kaddurah-Daouk, Rima
2013
9 4S p. P571
artikel
71 Alterations in structure and perfusion in Alzheimer’s disease–related brain areas depend on beta-amyloid accumulation in healthy controls and MCI patients Mattsson, Niklas
2013
9 4S p. P534-P535
artikel
72 Alterations of neurotrophin signaling in the retina of the P301S mutant human tau transgenic mouse Barini, Erica
2013
9 4S p. P169
artikel
73 Altered arginine metabolism in the Alzheimer's hippocampus Liu, Ping
2013
9 4S p. P346
artikel
74 Altered blood thiamine metabolism in Alzheimer's disease Zhong, Chunjiu
2013
9 4S p. P127-P128
artikel
75 Altered connectome mapping in mild cognitive impairment and older adults with cognitive complaints Wang, Yang
2013
9 4S p. P71
artikel
76 Altered connectome mapping in people with mild cognitive impairment and older adults with cognitive complaints Wang, Yang
2013
9 4S p. P276
artikel
77 Altered white-matter integrity and neurocognitive outcome in first-episode, drug-naive elderly with late-onset depression: A tract-based spatial statistics study Wang, Xiao
2013
9 4S p. P419-P420
artikel
78 Alzheimer Disease: The “State of the State” DeKosky, Steven
2013
9 4S p. P1
artikel
79 Alzheimer's disease and Down syndrome Lemere, Cynthia
2013
9 4S p. P513
artikel
80 Alzheimer's disease biomarkers and normative cognitive data: The SuperNorms approach Chasse, Rachel
2013
9 4S p. P877-P878
artikel
81 Alzheimer's disease biomarkers as outcome measures for clinical trials Caroli, Anna
2013
9 4S p. P727-P728
artikel
82 Alzheimer's disease ‘brainprint’: How to use information from the whole brain to detect Alzheimer’s disease before dementia Chetelat, Gael
2013
9 4S p. P45
artikel
83 Alzheimer's disease "brainprint": How to use information from the whole brain to detect Alzheimer's disease before dementia Chetelat, Gael
2013
9 4S p. P579-P580
artikel
84 Alzheimer's disease can be accurately differentiated from semantic dementia using automated measurement of hippocampal asymmetry Gordon, Elizabeth
2013
9 4S p. P34-P35
artikel
85 Alzheimer's disease diagnosis and monitoring using retinal imaging Baum, Larry
2013
9 4S p. P867
artikel
86 Alzheimer's disease diagnosis by detecting exogeneous fluorescent signal of ligand bound to beta-amyloid in the lenses of human eyes: An exploratory study Kerbage, Charles
2013
9 4S p. P735
artikel
87 Alzheimer's disease: Finding the missing heritability Ridge, Perry
2013
9 4S p. P553-P554
artikel
88 Alzheimer's disease, Lewy body disease and TDP43 proteinopathy following a single TBI Daneshvar, Daniel
2013
9 4S p. P438
artikel
89 Alzheimer's disease prevention research in the California Teachers Study cohort Lee, Eunjung
2013
9 4S p. P614
artikel
90 Alzheimer's disease: Using frequency-doubling technology to identify potential visual system biomarkers Valenti, Denise A.
2013
9 4S p. P777-P778
artikel
91 Alzheimer's Prevention Initiative Colombia registry in the PSEN1 E280A mutation kindred Lopera, Francisco
2013
9 4S p. P321
artikel
92 Alzheimer’s targets brain networks: The perspective from diffusion tensor imaging (DTI) Fellgiebel, Andreas
2013
9 4S p. P312-P313
artikel
93 Alzheimer's targets brain networks: The perspective from multimodal neuroimaging Villain, Nicolas
2013
9 4S p. P313-P314
artikel
94 A machine-learning approach for integration of computerized cognitive data in the neuropsychological assessment of older adults Mishan-Shamay, Hila
2013
9 4S p. P635-P636
artikel
95 Amantadine and AChE inhibitor hybrids as candidates for Alzheimer's disease treatment Korabecny, Jan
2013
9 4S p. P805
artikel
96 Amelioration of Alzheimer's disease by the neuroprotective effect of sulforaphane in an animal model Kim, Hye Yun
2013
9 4S p. P162-P163
artikel
97 Amelioration of calcium dyshomeostasis by immunotherapy with BIIB037 in Tg2576 mice Kastanenka, Ksenia
2013
9 4S p. P508
artikel
98 Ameliorative role of Centella asiatica against aluminum-toxicity–induced cognitive dysfunction in rats Prakash, Atish
2013
9 4S p. P155
artikel
99 A model of Alzheimer's disease by intra-CA1 injection of beta-amyloid 25-35 in rats Moosavi, Maryam
2013
9 4S p. P154
artikel
100 A molecular mechanism by which acidosis of the brain can lead to Alzheimer's disease Basurto-Islas, Gustavo
2013
9 4S p. P307
artikel
101 A momentary visual presentation task can discriminate semantic dementia from Alzheimer's disease as demonstrating semantic memory access disorders: The Osaki-Tajiri Project Takahashi, Yumi
2013
9 4S p. P866
artikel
102 A 6-month aerobic exercise program is associated with increased hippocampal volume in older African-Americans Iyalomhe, Osi
2013
9 4S p. P635
artikel
103 AMP-activated protein kinase activation ameliorates mitochondrial abnormalities and neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease Du, Lai-Ling
2013
9 4S p. P509
artikel
104 A multicenter clinical trial to validate event-related potentials as useful biomarkers for early detection of Alzheimer's disease Cecchi, Marco
2013
9 4S p. P197-P198
artikel
105 A multicenter, randomized trial to assess efficacy of home-based and group cognitive intervention programs in amnestic mild cognitive impairment Na, Hae Ri
2013
9 4S p. P495
artikel
106 A multidisciplinary program model: Evaluation, treatment and long-term follow-up for people with dementia and their caregivers Megas, Susan
2013
9 4S p. P744
artikel
107 A multidisciplinary treatment protocol for enhancing memory and brain performance: Brain Fitness Program Sahin-Mudd, Eylem
2013
9 4S p. P799
artikel
108 A multimodal imaging study of mAb158, a murine monoclonal antibody with high selectivity for amyloid protofibrils, in Tg2576 mice Navia, Bradford
2013
9 4S p. P808
artikel
109 Amyloid and vascular cognitive impairment: A pilot study of frequency and impact Dao, Elizabeth
2013
9 4S p. P382
artikel
110 Amyloid, apolipoprotein E (APOE) and age in relation to longitudinal FDG metabolism and clinical decline in cognitively normal and mildly impaired elderly Becker, John
2013
9 4S p. P316-P317
artikel
111 Amyloid-associated alterations in metabolic connectivity patterns in ADNI participants Charil, Arnaud
2013
9 4S p. P418-P419
artikel
112 Amyloid-associated alterations in metabolic connectivity patterns in ADNI participants Charil, Arnaud
2013
9 4S p. P11
artikel
113 Amyloid burden measured by T1-rho–weighted MRI in Down syndrome Koran, Mary Ellen
2013
9 4S p. P87
artikel
114 Amyloid burden measured by T1-rho-weighted MRI in Down syndrome Koran, Mary Ellen
2013
9 4S p. P264-P265
artikel
115 Amyloid cascade peptides in mild cognitive impairment with regard to Alzheimer's disease cerebral metabolic signature Alexopoulos, Panagiotis
2013
9 4S p. P216
artikel
116 Amyloid hubs in individual PiB-PET imaging Sepulcre, Jorge
2013
9 4S p. P581-P582
artikel
117 Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later Roe, Catherine
2013
9 4S p. P724
artikel
118 Amyloidogenic properties of isoAsp7-containing beta-amyloid peptide Kozin, Sergey
2013
9 4S p. P857
artikel
119 Amyloid PET imaging in clinical practice DeKosky, Steven
2013
9 4S p. P125
artikel
120 Amyloid PET screening for enrollment into Alzheimer's disease clinical trials: An effective enrichment strategy in a phase 1b clinical trial Barakos, Jerome
2013
9 4S p. P249
artikel
121 Amyloid PET screening results by APOE-ε4 status from a phase 1b clinical study of 221AD103 in people with prodromal to mild Alzheimer's disease Chiao, Ping
2013
9 4S p. P291
artikel
122 Amyloid-positive MCI: Predicting progression to dementia Chertkow, Howard
2013
9 4S p. P149-P150
artikel
123 Amyloid-related imaging abnormalities (ARIA) in undosed and anti-beta-amyloid monoclonal antibody–dosed APP+PS1 Mice Angus, William
2013
9 4S p. P165
artikel
124 Amyloid status and neuropsychological profiles in early-onset, late-onset and very late-onset dementia due to probable Alzheimer's disease McGinnis, Scott
2013
9 4S p. P372
artikel
125 An ADAM protein as a new actor of the APP metabolism Letronne, Florent
2013
9 4S p. P185
artikel
126 An aglycosylated murine antibody surrogate of ponezumab reduces vascular beta-amyloid 1-40 with no increase in microhemorrhages in aged Tg2576 mice Freeman, Gary
2013
9 4S p. P500
artikel
127 Analysis of cognition, CSF and neuroimaging in cases of progressive aphasia Ikeda, Masaki
2013
9 4S p. P865
artikel
128 Analysis of loci from genome-wide association studies of many complex traits for association with late-onset Alzheimer's disease (LOAD) identifies potentially pleiotropic variants Wang, Li-San
2013
9 4S p. P124
artikel
129 Analysis of relationships between cortical structural connections, global and local amyloid burden, and cognitive performace in Alzheimer's dementia Prescott, Jeffrey
2013
9 4S p. P76
artikel
130 Analysis of relationships between cortical structural connections, global and local amyloid burden and cognitive performance in Alzheimer's dementia Prescott, Jeffrey
2013
9 4S p. P832
artikel
131 Analysis of stereopsis of people with Alzheimer's dementia using 3-dimensional television Lee, Chan-Nyoung
2013
9 4S p. P470
artikel
132 Analysis of the profile of unfolded protein response (UPR) markers in model-systems of Alzheimer's disease Stefani, Ioanna
2013
9 4S p. P143-P144
artikel
133 Analysis of the synapse-rich brain proteome reveals potential markers of asymptomatic Alzheimer's disease Higginbotham, Lenora
2013
9 4S p. P331
artikel
134 An Alzheimer's pathology manipulation: The impact of inositol hexakisphosphate on endogenous beta-amyloid aggregation in APP-transfected neuroblastoma 2a cells in hydrogen peroxide environments Mandal, Nivedita
2013
9 4S p. P812-P813
artikel
135 Anatomical correlates of primary progressive aphasia subtypes using SPGR 3D volumetric analysis Jeong, Jee-Hyang
2013
9 4S p. P387-P388
artikel
136 A naturally occurring human IgG specific for oligomeric and fibrillar beta-amyloid: In vitro and in vivo studies Puligedda, Rama Devudu
2013
9 4S p. P857
artikel
137 An early biomarker of functional disconnectivity and subsequent cognitive decline Hsu, Chun Liang
2013
9 4S p. P834-P835
artikel
138 An early fMRI marker of semantic memory deficits in people with amnestic mild cognitive impairment Chiang, Hsueh-Sheng
2013
9 4S p. P580
artikel
139 An educational program for nursing assistants: Preventing agitation in the hospitalized person with dementia Altsman, Laurie-Ann
2013
9 4S p. P479-P480
artikel
140 Anemia and risk of dementia in older biracial adults: Findings from the Health ABC study Hong, Chang Hyung
2013
9 4S p. P613-P614
artikel
141 A new EEG index for Alzheimer's disease diagnosis Anghinah, Renato
2013
9 4S p. P370
artikel
142 A new era of CSF biomarker testing in the field of Alzheimer's disease Engelborghs, Sebastiaan
2013
9 4S p. P211
artikel
143 A new in vitro screening liaison: Direct effects on beta-amyloid oligomer formation and beneficial impacts on neuroprotection Taub, Nicole
2013
9 4S p. P186
artikel
144 A new model of aging and dementia: Focus on C-terminal domain of amyloid precursor protein and Y682ENPTY687 motif Matrone, Carmela
2013
9 4S p. P328
artikel
145 A new simple score (ABS) for screening behavioral and psychological symptoms of dementia Abe, Koji
2013
9 4S p. P734
artikel
146 An examination of regulatory function for GWAS-confirmed and suggestive loci of late-onset Alzheimer's disease Rosenthal, Samantha
2013
9 4S p. P552
artikel
147 An exploration of a functional unit of DNA methylation in the aging brain Keenan, Brendan
2013
9 4S p. P172
artikel
148 An immune profile of age, gender and race in protein expression of CD33 Tang, Anna
2013
9 4S p. P570-P571
artikel
149 An interdisciplinary counseling center for individuals, couples and families affected by MCI and dementia Alli, Rabeena
2013
9 4S p. P646
artikel
150 An interdisciplinary outpatient cognitive rehabilitation program for people with dementia Cohen, Gabriela
2013
9 4S p. P798
artikel
151 An Internet-based survey assessing public attitudes about preclinical testing for Alzheimer's disease Caselli, Richard
2013
9 4S p. P545-P546
artikel
152 An old drug for new therapy: Characterization of cancer drug IRX204 as a beta-sheet breaker agent for treatment of neurodegenerative disorders Pasinetti, Giulio
2013
9 4S p. P819-P820
artikel
153 A noninvasive device-based approach to aid in the diagnosis of mTBI and Alzheimer's disease: Preliminary findings from Clinical Pilot Studies Simon, Adam
2013
9 4S p. P222
artikel
154 A novel Alzheimer's disease model based on 3D-cultured human neural progenitor cells Kim, Young Hye
2013
9 4S p. P710
artikel
155 A novel BACE inhibitor (PF-05297909): A two-part adaptive design to evaluate safety, pharmacokinetics and pharmacodynamics for modifying beta-amyloid in a first-in-human study Bell, Joanne
2013
9 4S p. P287
artikel
156 A novel link between clusterin and tau pathology in Alzheimer's disease Hayashi, Ikuo
2013
9 4S p. P853
artikel
157 A novel LXRα- or RX-independent mechanism for increasing brain APOE levels Sylvain, Emily
2013
9 4S p. P855
artikel
158 A novel mechanism by which beta-amyloid 42 initiates mitochondrial abnormality in the synapse Sekiya, Michiko
2013
9 4S p. P520-P521
artikel
159 A novel mechanism that targets misfolded protein assemblies Krishnan, Rajaraman
2013
9 4S p. P361-P362
artikel
160 A novel method for enhancement of peptide vaccination utilizing T-cell epitopes from conventional vaccines Kanazawa, Yoshito
2013
9 4S p. P503
artikel
161 A novel PKC-dependent phosphorylation of doublecortin: Potential implications in the context of excitotoxicity Bruban, Julien
2013
9 4S p. P565
artikel
162 A novel triple-repeat mutant tau transgenic model that mimics aspects of Pick's disease and frontotemporal tauopathies Rockenstein, Edward
2013
9 4S p. P168
artikel
163 A novel way of thinking of a solution for Alzheimer's disease Fernando, Warnakulasuriya
2013
9 4S p. P281
artikel
164 An overview of the clinical assessment tools for Alzheimer's disease in Mexico: The National Dementia Survey—A study from the Mexican group of specialists in dementias Diaz, Santiago Ramirez
2013
9 4S p. P759
artikel
165 An overview of the medical food Souvenaid clinical trial program Wieggers, R.L.
2013
9 4S p. P669
artikel
166 Antemortem MRI findings associated with presence of microinfarcts at autopsy Raman, Mekala
2013
9 4S p. P36
artikel
167 Antemortem MRI findings associated with presence of microinfarcts at autopsy Raman, Mekala
2013
9 4S p. P389-P390
artikel
168 Anti-aggregation effect of AA-peptide on beta-amyloid peptides in Alzheimer's disease Bai, Ge
2013
9 4S p. P364-P365
artikel
169 Antidementia drugs are related to changes in gait: Which drugs for which walking condition? Beauchet, Olivier
2013
9 4S p. P294
artikel
170 Anti-hyperglycemic therapy and risk of dementia: A new user cohort study Whitmer, Rachel
2013
9 4S p. P136
artikel
171 Anti-malarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of NF-κB and NLRP3 inflammasome activation Shi, Jian-Quan
2013
9 4S p. P152
artikel
172 Anti-oxidant and anti-excitotoxic effects of date, fig and walnut extracts in human neurons Selvaraju, Subash
2013
9 4S p. P801
artikel
173 Antipsychotic efficacy and good tolerability in a Phase III placebo-controlled study of pimavanserin in patients with Parkinson's disease psychosis (ACP-103-020) Ballard, Clive
2013
9 4S p. P690
artikel
174 Antisense oligonucleotide-mediated inhibition of miR-33 in cultured neurons, astrocytes and microglia: Effects on ABCA1 expression, APOE lipidation, cellular cholesterol and beta-amyloid neurotoxicity Qureshi, Asad
2013
9 4S p. P893
artikel
175 Antithrombotic medication use and dementia incidence among people with mild cognitive impairment and atrial fibrillation Meranus, Dana
2013
9 4S p. P612
artikel
176 An unusual case of logopenic progressive aphasia associated with corticobasal syndrome Jiskoot, Lize
2013
9 4S p. P747
artikel
177 An unusual case of logopenic progressive aphasia associated with corticobasal syndrome Jiskoot, Lize
2013
9 4S p. P23
artikel
178 An updated systematic review of the impact of medications with anticholinergic activity on cognitive function and mortality Maidment, Ian
2013
9 4S p. P774
artikel
179 A nutritional formulation for cognitive performance and mood in Alzheimer's disease and mild cognitive impairment: A phase II multisite randomized trial with an open-label extension Shea, Thomas
2013
9 4S p. P658-P659
artikel
180 Anxiety but not depression affects self-reported spatial navigation difficulties irrespective of the real-space navigation performance in individuals at risk of Alzheimer's disease Sheardova, Katerina
2013
9 4S p. P790-P791
artikel
181 Apathy and white matter in Alzheimer's disease: A whole-brain analysis with tract-based spatial statistics Lee, Chang Uk
2013
9 4S p. P373-P374
artikel
182 Apathy: A persistent neuropsychiatric syndrome with increased mortality—Results from the Medical Research Council Cognitive Function and Ageing Study van der Linde, Rianne
2013
9 4S p. P538
artikel
183 A pharmacogenetics-supported clinical trial to delay onset of mild cognitive impairment due to Alzheimer's disease Roses, Allen
2013
9 4S p. P727
artikel
184 A phase I clinical trial suggests nutritional supplement combination therapy is feasible, safe and tolerable in cognitively normal adults Auerbach, Sanford
2013
9 4S p. P662
artikel
185 A phase II double-blind, placebo-controlled randomized trial of an escalating dose of thalidomide in the treatment of Alzheimer's disease: Baseline characteristics Sabbagh, Marwan
2013
9 4S p. P285
artikel
186 A phase II randomized, double-blind, parallel group, 26-week study of GSK-3 inhibitor tideglusib in Alzheimer's disease (ARGO trial) del Ser, Teodoro
2013
9 4S p. P689-P690
artikel
187 A phase II safety and tolerability study to investigate the effect of AZD5213 on sleep in subjects with mild cognitive impairment and mild Alzheimer's disease Hannesdottir, Kristin
2013
9 4S p. P891-P892
artikel
188 A phase II study of the gamma-secretase inhibitor avagacestat (BMS-708163) in predementia Alzheimer's disease Coric, Vlad
2013
9 4S p. P283
artikel
189 A phase I trial of parenchymal injection of umbilical cord stem cells in Alzheimer's disease Seo, Sang Won
2013
9 4S p. P291
artikel
190 Aphasia with left occipitotemporal hypometabolism: A novel presentation of posterior cortical atrophy? Wicklund, Meredith
2013
9 4S p. P749
artikel
191 A phenomenological study of realistic picture copy in a case of advanced semantic dementia Radanovic, Márcia
2013
9 4S p. P799
artikel
192 A pilot, randomized study of music therapy for people with Alzheimer's disease Hsiung, Ging-Yuek
2013
9 4S p. P477
artikel
193 APOE and APOE receptors in brain lipid metabolism, synaptic functions and clearance of beta-amyloid Bu, Guojun
2013
9 4S p. P121
artikel
194 APOE-ɛ4 and clinical progression in Parkinson's disease Monsell, Sarah
2013
9 4S p. P738-P739
artikel
195 APOE genotype and gender influence glucose tolerance in older adults with cognitive impairment Hanson, Angela
2013
9 4S p. P767-P768
artikel
196 APOE genotype and the risk of dementia in the oldest-old: The Monzino 80-plus study Lucca, Ugo
2013
9 4S p. P614
artikel
197 APOE genotype by gender interaction revealed in CSF biomarkers and clinical conversion rates in the ADNI database Altmann, Andre
2013
9 4S p. P245-P246
artikel
198 APOE-ε4 is associated with increased hippocampal atrophy rates in Alzheimer's disease Manning, Emily
2013
9 4S p. P251
artikel
199 APOE-ε4 is associated with increased hippocampal atrophy rates in Alzheimer's disease Manning, Emily
2013
9 4S p. P5
artikel
200 APOE-ε2: Molecular features, biomarker signature, and neurobehavioral implications Goldberg, Terry
2013
9 4S p. P826
artikel
201 APOE-stratified genome-wide association analysis reveals differential effects by APOE status and potential new risk loci for Alzheimer's disease Ibrahim-Verbaas, Carla
2013
9 4S p. P123
artikel
202 Apolipoprotein E ε-4 affects the cortical decline in Alzheimer's disease Kim, Yeo Jin
2013
9 4S p. P601
artikel
203 Apolipoprotein E allele and angiotensin-converting enzyme and its inhibitors in the development of Alzheimer's disease Wallack, Max
2013
9 4S p. P616-P617
artikel
204 Apolipoprotein E-ε4 as a risk factor for Alzheimer's dementia: Is delirium the key? Caplan, Gideon
2013
9 4S p. P356
artikel
205 Apolipoprotein E-ɛ4 genotype influences spatial distribution of cerebral microbleeds Loehrer, Elizabeth
2013
9 4S p. P705
artikel
206 Apolipoprotein E genotype influences spatial distribution of cerebral microbleeds Loehrer, Elizabeth
2013
9 4S p. P82
artikel
207 Apolipoprotein E-ε4 in a Japanese population with Alzheimer's disease and dementia with Lewy bodies Tateno, Masaru
2013
9 4S p. P366
artikel
208 Apoptosis induced by overexpression of APP requires its localization to mitochondria Wilkins, Heather
2013
9 4S p. P348
artikel
209 A potential pathogenic effect of a novel PSEN2 mutation (Val214Leu) detected in Korea Youn, Young Chul
2013
9 4S p. P178-P179
artikel
210 A power analysis for multisite studies in resting-state functional connectivity, with an application to clinical trials in Alzheimer's disease Dansereau, Christian
2013
9 4S p. P248-P249
artikel
211 APP a common target for neuropathology treatment Solomon, Beka
2013
9 4S p. P840-P841
artikel
212 APP and APLP2 are necessary for proper axon guidance of a regenerating neural circuit Albers, Mark
2013
9 4S p. P847
artikel
213 Appetite alterations: A subcortical AGD symptom? Rodriguez-Diehl, Roberta
2013
9 4S p. P436-P437
artikel
214 APPxPS1dE9 mice display neuronal dysfunction at an asymptomatic state of amyloidosis Ly, Myriam
2013
9 4S p. P712
artikel
215 Apraxia as initial presentation of Alzheimer's disease: A case series Christie, Corina
2013
9 4S p. P751-P752
artikel
216 A preliminary analysis of cerebral amyloid angiopathy (CAA)–related hemorrhage in China Xu, Jun
2013
9 4S p. P440-P441
artikel
217 A preliminary resting-state fMRI study of regionally reduced complexity patterns in Alzheimer's disease Liu, Yinan
2013
9 4S p. P86-P87
artikel
218 A preliminary resting-state fMRI study of regionally reduced complexity patterns in Alzheimer's disease Liu, Yinan
2013
9 4S p. P278
artikel
219 A proportional odds approach for estimating probability of cognitive health, MCI and dementia associated with computerized cognitive testing score Doniger, Glen
2013
9 4S p. P636
artikel
220 A quadratic, P-spline, mixed model to predict cognitive decline in Alzheimer's disease Mouiha, Abderazzak
2013
9 4S p. P203-P204
artikel
221 A quadratic P-spline mixed model to predict cognitive decline in Alzheimer's disease Mouiha, Abderazzak
2013
9 4S p. P33-P34
artikel
222 A randomized controlled trial investigating the effects of Souvenaid in prodromal Alzheimer's disease: Baseline characteristics of the LipiDiDiet study Visser, Pieter Jelle
2013
9 4S p. P669-P670
artikel
223 A randomized controlled trial of psychosocial interventions for old-old people with mild cognitive impairment (MCI): Patient-reported outcomes—The Kurihara project Nakamura, Kei
2013
9 4S p. P492
artikel
224 A randomized controlled trial of psychosocial interventions for old-old people with mild cognitive impairment (MCI): Physical and neuropsychological outcomes—The Kurihara project Nakatsuka, Masahiro
2013
9 4S p. P492-P493
artikel
225 A randomized, double-blind, placebo-controlled clinical trial of Korean ginseng as a functional food in mild cognitive impairment Park, Keychung
2013
9 4S p. P804
artikel
226 A randomized, double-blind, placebo-controlled, multiple ascending dose study to evaluate the safety, tolerability and pharmacokinetics of a microtubule stabilizer (BMS-241027) in healthy females Malamut, Richard
2013
9 4S p. P668-P669
artikel
227 A rare coding variant alters UNC5C function and predisposes to Alzheimer's disease Hunkapiller, Julie
2013
9 4S p. P853
artikel
228 A rare coding variant in PLD3 confers high risk for Alzheimer's disease Cruchaga, Carlos
2013
9 4S p. P312
artikel
229 A rare variant alters UNC5C function and predisposes to Alzheimer's disease Graham, Robert
2013
9 4S p. P311
artikel
230 A reduced risk of Alzheimer's disease is associated with the majority of cancers in a national cohort of veterans Frain, Laura
2013
9 4S p. P617
artikel
231 Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent? Kinnunen, Kirsi
2013
9 4S p. P3-P4
artikel
232 Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent? Kinnunen, Kirsi
2013
9 4S p. P251-P252
artikel
233 A refined cortical signature of Alzheimer's disease Wang, Liang
2013
9 4S p. P424-P425
artikel
234 A refined cortical signature of Alzheimer’s disease Wang, Liang
2013
9 4S p. P69
artikel
235 Are metabolic risk factors also risk factors for Alzheimer's disease or vascular dementia? Chui, Helena
2013
9 4S p. P121
artikel
236 Are older brains getting younger? Changes in cerebral amyloid deposition over a 30-year period Gold, Gabriel
2013
9 4S p. P434
artikel
237 Are our animal models good enough? Borchelt, David
2013
9 4S p. P827
artikel
238 Are some individuals immune to dementia? Wang, Linbo
2013
9 4S p. P617-P618
artikel
239 Are the effects of age and education on neuropsychological performance the same in healthy individuals, individuals with mild cognitive impairment and those with Alzheimer's disease? Lubrini, Genny
2013
9 4S p. P462
artikel
240 Are there cognitive benefits from long-term high-intensity exercise in older adults? Young, Jeremy
2013
9 4S p. P879-P880
artikel
241 A review of published genetic studies using ADNI multimodality quantitative phenotypes: MRI, PET, fluid biomarkers, cognition and clinical status Shen, Li
2013
9 4S p. P78-P80
artikel
242 A review of published genetic studies using ADNI multimodality quantitative phenotypes: MRI, PET, fluid biomarkers, cognition and clinical status Shen, Li
2013
9 4S p. P220
artikel
243 Arf6 controls rapid lysosomal transport of cell surface APP and beta-amyloid production by macropinocytosis Pasternak, Stephen
2013
9 4S p. P532
artikel
244 Argentina ADNI: Preliminary report on CSF biomarkers Sevlever, Gustavo
2013
9 4S p. P371-P372
artikel
245 Arginase-1 overexpression reduces tau pathology in rTg4510 tau transgenic mice Hunt Jr., Jerry
2013
9 4S p. P307-P308
artikel
246 Arterial spin labeling cerebral blood flow and brain volumes in dementia-free elderly Silbert, Lisa
2013
9 4S p. P267
artikel
247 Arterial spin labeling cerebral blood flow and brain volumes in dementia-free elderly Lahna, David
2013
9 4S p. P27-P28
artikel
248 Arterial stiffness is associated with amyloid deposition in the brain independent of blood pressure Kuller, Lewis
2013
9 4S p. P543-P544
artikel
249 Arterial stiffness is associated with amyloid deposition in the brain independent of blood pressure Hughes, Timothy
2013
9 4S p. P19-P20
artikel
250 Art therapy with a group of dementia caregivers: Exploring wellbeing through social support and creative expression Reid, Scott
2013
9 4S p. P485
artikel
251 A self-amplifying loop between thermogenesis and Alzheimer's disease neuropathology in 3xTg-AD mice Vandal, Milene
2013
9 4S p. P510
artikel
252 A simple clinical index to predict conversion from mild cognitive impairment to Alzheimer's disease within 3 years Lee, Sei
2013
9 4S p. P696-P697
artikel
253 A single ascending-dose study of BIIB037 in people with mild-to-moderate Alzheimer's disease Sevigny, Jeffrey
2013
9 4S p. P290
artikel
254 A single night of sleep deprivation increases cerebrospinal fluid beta-amyloid 42 protein in healthy male volunteers Ooms, Sharon
2013
9 4S p. P521
artikel
255 Assessing long-term postoperative cognitive decline using conventional and quasi-experimental approaches: A Monte Carlo simulation study Llewellyn, David
2013
9 4S p. P343
artikel
256 Assessing rates of cognitive decline in Alzheimer's disease and dementia with Lewy bodies Ard, M. Colin
2013
9 4S p. P788
artikel
257 Assessing the economic value of potential disease-modifying agents in Alzheimer's disease using simulation Getsios, Denis
2013
9 4S p. P467
artikel
258 Assessment of Alzheimer's disease risk genes with CSF-biomarker levels Schjeide, Brit-Maren
2013
9 4S p. P179
artikel
259 Assessment of cardiorespiratory fitness and endurance in people with Alzheimer's disease: Preliminary results Sobol, Nanna
2013
9 4S p. P665-P666
artikel
260 Assessment of cerebral vasoreactivity using ultrasound techniques in Alzheimer's disease Giubilei, Franco
2013
9 4S p. P442
artikel
261 Assessment of cognitive deficits and blood biomarkers of neurodegenerative disease progression in an aged nonhuman primate Languille, Solène
2013
9 4S p. P155-P156
artikel
262 Assessment of hippocampal volumetry in a transgenic Alzheimer's disease rat Shin, Monica
2013
9 4S p. P248
artikel
263 Assessment of hippocampal volumetry in transgenic Alzheimer’s disease rats Shin, Monica
2013
9 4S p. P28-P29
artikel
264 Assessment of retinal microvasculature may aid dementia subtype differentiation Ong, Yi-Ting
2013
9 4S p. P331-P332
artikel
265 Assessment of TREM2 R47H in a population-based sample: The Cache County Study Gonzalez, Josue
2013
9 4S p. P556-P557
artikel
266 Associating Wechsler Memory Scale Logical Memory (LM) errors and correct responses and MRI regions of interest from a healthy community-dwelling cohort: The Framingham Heart Study Libon, David
2013
9 4S p. P443
artikel
267 Association between bone mineral density and cognitive impairment among community-dwelling adults without dementia and stroke Park, Hyunyoung
2013
9 4S p. P634
artikel
268 Association between brain atrophy rates from MRI and future cognitive decline Leung, Kelvin
2013
9 4S p. P148-P149
artikel
269 Association between cerebrovascular reactivity, cardiac output and frailty in mild cognitive impairment Bell, Susan
2013
9 4S p. P273
artikel
270 Association between cognitive complaint and depressive symptoms in elderly individuals at risk of developing Alzheimer's disease Dion, Melissa
2013
9 4S p. P444
artikel
271 Association between cortical thickness and CSF biomarkers in mild cognitive impairment and Alzheimer’s disease Mohades, Sara
2013
9 4S p. P70
artikel
272 Association between cortical thickness and CSF biomarkers in mild cognitive impairment and Alzheimer's disease Mohades, Sara
2013
9 4S p. P223-P224
artikel
273 Association between head trauma, amyloid and neurodegeneration in a population-based study of cognitively normal and mild cognitive impairment participants Mielke, Michelle
2013
9 4S p. P23-P24
artikel
274 Association between head trauma, amyloid, and neurodegeneration in a population-based study of cognitively normal participants and participants with mild cognitive impairment Mielke, Michelle
2013
9 4S p. P616
artikel
275 Association between higher fasting serum glucose levels and the pattern of lower regional gray matter volumes in cognitively normal adults Bartell, Jared
2013
9 4S p. P93
artikel
276 Association between higher fasting serum glucose levels and the pattern of lower regional gray matter volumes in cognitively normal adults Bartell, Jared
2013
9 4S p. P196-P197
artikel
277 Association between memory and amyloid deposition and synaptic dysfunction in EMCI, LMCI and Alzheimer’s disease patients Dauar, Marina
2013
9 4S p. P132-P133
artikel
278 Association between memory and amyloid deposition–synaptic dysfunction in people with EMCI, LMCI and Alzheimer’s disease Dauar, Marina
2013
9 4S p. P24-P25
artikel
279 Association between the Alzheimer's disease–related hypometabolic convergence index and clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative Roontiva, Auttawut
2013
9 4S p. P698
artikel
280 Association between the Alzheimer's disease-related hypometabolic convergence index and clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative Roontiva, Auttawut
2013
9 4S p. P92-P93
artikel
281 Association between vitamin D binding protein (VDBP) haplotype and late-onset Alzheimer's disease Araz, Omur Selin
2013
9 4S p. P177
artikel
282 Association between vitamin D concentration and dementia: A population-based cross-sectional study among elderly people in Southern Germany von Arnim, Christine
2013
9 4S p. P619
artikel
283 Association of ankle brachial index among the elderly with normal cognition, amnestic mild cognitive impairment and Alzheimer's disease Kim, Shin Gyeom
2013
9 4S p. P729-P730
artikel
284 Association of BMI and change in BMI with cognitive function, change in cognitive function and conversion to Alzheimer's disease Zhang, Ping
2013
9 4S p. P785-P786
artikel
285 Association of genetic variants with cerebrospinal fluid protein levels of ACE, MMP3 and other proteins and risk for Alzheimer's disease Kauwe, John
2013
9 4S p. P677-P678
artikel
286 Association of gray matter atrophy with age, beta-amyloid, white matter hyperintensity and cognition in normal aging Oh, Hwamee
2013
9 4S p. P701-P702
artikel
287 Association of long-term heavy aluminum intake and involuntary movements with cognitive decline Jang, Hyun
2013
9 4S p. P732
artikel
288 Association of magnetic resonance imaging white matter lesions and cognitive decline in Alzheimer's disease Mikula, Margit
2013
9 4S p. P701
artikel
289 Association of plasma beta-amyloid levels and risk of dementia, Alzheimer's disease, brain structure and cognitive functions in the Framingham Heart Study Chouraki, Vincent
2013
9 4S p. P238-P239
artikel
290 Association of TREM2 variants with Alzheimer's disease in African-Americans: For the Alzheimer's Disease Genetics Consortium (ADGC) Reitz, Christiane
2013
9 4S p. P175
artikel
291 Association of unrecognized preoperative cognitive impairment with postoperative cognitive and functional outcomes in elderly people awaiting hip fracture repair Daiello, Lori
2013
9 4S p. P777
artikel
292 Associations of physical activity, insomnia and cognitive impairment in older adults Chen, Li-Jung
2013
9 4S p. P632
artikel
293 Associations of physical activity with cognitive impairment in Taiwanese older adults: Eight-year follow-up Ku, Po-Wen
2013
9 4S p. P632
artikel
294 Association study of late-onset Alzheimer's disease risk variants and memory decline Carrasquillo, Minerva
2013
9 4S p. P706
artikel
295 Association study of late-onset Alzheimer's disease risk variants and risk for posterior cortical atrophy Carrasquillo, Minerva
2013
9 4S p. P553
artikel
296 A standard benchmark for assessing the reproducibility of brain atrophy measures in Alzheimer's disease using the ADNI1 data set Cover, Keith
2013
9 4S p. P592
artikel
297 A standard benchmark for assessing the reproducibility of brain atrophy measures in Alzheimer's disease using the ADNI1 data set Cover, Keith
2013
9 4S p. P43
artikel
298 A standardized method for Freesurfer quality control Ercole, Lindsay
2013
9 4S p. P604
artikel
299 Astrocytosis precedes amyloid deposition in Alzheimer’s disease Tg2576 APPswe transgenic mice: A multitracer microPET imaging study Rodriguez-Vieitez, Elena
2013
9 4S p. P28
artikel
300 Astrocytosis precedes amyloid deposition in Alzheimer's Tg2576 APPswe transgenic mice: A multi-tracer microPET imaging study Rodriguez-Vieitez, Elena
2013
9 4S p. P337
artikel
301 A study of working memory and predictive capacity investigated by saccadic eye movements in healthy volunteers and people with mild Alzheimer's disease Ruthirakuhan, Myuri
2013
9 4S p. P734
artikel
302 A study to assess the safety, tolerability and effectiveness of NUEDEXTA (dextromethorphan 20 mg/quinidine 10 mg) in the treatment of pseudobulbar affect (PBA) [PRISM-II] Doody, Rachelle
2013
9 4S p. P662
artikel
303 A systematic analysis of genomic changes in Tg2576 mice Tan, Lu
2013
9 4S p. P179-P180
artikel
304 A systematic evaluation of the preclinical pharmacokinetic/pharmacodynamic relationship of Alzheimer's disease gold standard drugs in the rat: An in vitro, ex vivo and in vivo comparison Jones, Caitlin
2013
9 4S p. P815
artikel
305 A systematic review of the relationship between parathyroid hormone levels and cognitive function and dementia Lourida, Ilianna
2013
9 4S p. P627
artikel
306 A systems genetic approach to understand late-onset Alzheimer's disease in mice Howell, Gareth
2013
9 4S p. P163
artikel
307 A theory elucidates the fundamentals of Alzheimer's disease at molecular level Xia, John
2013
9 4S p. P820
artikel
308 A theory elucidates the fundamentals of Alzheimer's disease at the molecular level Xia, Jun
2013
9 4S p. P850
artikel
309 Atherosclerotic calcification is related to cognitive decline Vernooij, Meike
2013
9 4S p. P106
artikel
310 Atherosclerotic calcification is related to cognitive decline Vernooij, Meike
2013
9 4S p. P545
artikel
311 A time stamp imaging method for measuring the kinetics and toxicity of beta-amyloid and tau deposition by sequential multicolor labeling with beta-sheet binding dyes Yuan, Peng
2013
9 4S p. P164
artikel
312 A TOMM40 SNP in APOE-ε4 noncarriers increases risk for multiple types of dementia Bekris, Lynn
2013
9 4S p. P555
artikel
313 Atrial fibrillation and mild cognitive impairment Yaneva-Sirakova, Teodora
2013
9 4S p. P771
artikel
314 Atrophy correction enhances the diagnostic performance of florbetaben beta-amyloid PET imaging Barthel, Henryk
2013
9 4S p. P11
artikel
315 Atrophy in distinct corticolimbic networks predicts specific social symptoms in frontotemporal dementia Dickerson, Brad
2013
9 4S p. P377-P378
artikel
316 Attenuation of practice effects on neuropsychological performance is a potential marker of preclinical Alzheimer's disease Ruvolo, David
2013
9 4S p. P878-P879
artikel
317 Attitudes toward research in an urban minority population: A pilot study De La Fuente, Angelica
2013
9 4S p. P490-P491
artikel
318 Atypical antipsychotic efficacy and tolerability in dementia subjects living at a long-term care facility: A retrospective study Scharre, Douglas
2013
9 4S p. P653
artikel
319 Autoantibodies against tau, phosphorylated tau and PHF are produced in Alzheimer's disease and Down syndrome Wencheng, Liu
2013
9 4S p. P365
artikel
320 Automated diagnosis of Alzheimer's disease using multimodal analysis of surface-based FDG-uptake and cortical thickness Yun, Hyuk Jin
2013
9 4S p. P406-P407
artikel
321 Automated hippocampal subfield measures as predictors of conversion from mild cognitive impairment to Alzheimer's disease in two independent cohorts Khan, Wasim
2013
9 4S p. P275
artikel
322 Automated quantification of amyloid load using an atlas-based analysis in a mouse model of Alzheimer's disease Vandenberghe, Michel
2013
9 4S p. P401-P402
artikel
323 Automated quantification of amyloid load using an atlas-based analysis in a mouse model of Alzheimer's disease Vandenberghe, Michel
2013
9 4S p. P30
artikel
324 Automatic 11C PiB SUVR quantification Bourgeat, Pierrick
2013
9 4S p. P597
artikel
325 Automatic 11C PiB SUVR quantification Bourgeat, Pierrick
2013
9 4S p. P11-P12
artikel
326 Automatic diffusion-based fractional anisotropy measurements weighted by fiber density Schwarz, Adam
2013
9 4S p. P587-P588
artikel
327 Automatic diffusion-based fractional anisotropy measurements weighted by fiber density Schwarz, Adam
2013
9 4S p. P97
artikel
328 Autophagy and neurodegeneration Cuervo, Ana Maria
2013
9 4S p. P512
artikel
329 A vast difference in the levels of insoluble tau in commonly used tau mouse models Wu, Su
2013
9 4S p. P819
artikel
330 A virtual repository of biofluids to accelerate the identification of blood-based biomarkers of Alzheimer's disease Nosheny, Rachel
2013
9 4S p. P674-P675
artikel
331 A voxel-based morphometry comparison of the 3.0T ADNI-1 and ADNI-2 MPRAGE protocols Brunton, Simon
2013
9 4S p. P581
artikel
332 A way with metaphors: An analysis of literary work produced in early MCI due to Alzheimer's disease van Velzen, Marjolein
2013
9 4S p. P866-P867
artikel
333 A 24-week, open-label extension to the ACTivities of daily living and cognitION (ACTION) study: Long-term safety, tolerability and efficacy of a 13.3 mg/24 h rivastigmine patch in people with severe Alzheimer's disease Farlow, Martin
2013
9 4S p. P655
artikel
334 Axonal loss or demyelination? Decreased integrity of white matter tracts revealed by diffusional kurtosis imaging in Alzheimer's disease and mild cognitive impairment Gong, Nan-Jie
2013
9 4S p. P88-P89
artikel
335 Axonal trafficking inhibition in neurons depends on the aggregation state of Alzheimer's disease beta-amyloid peptides and their binding to the plasma membrane Trushina, Eugenia
2013
9 4S p. P532
artikel
336 AZD3293, a potent and selective orally active, brain-permeable BACE1 inhibitor Haeberlein, Samantha Budd
2013
9 4S p. P813
artikel
337 BACE1 gene regulation: A novel drug target in Alzheimer's disease Bayon, Baindu
2013
9 4S p. P304
artikel
338 Backed-up against the wall: Pharmacology to assuage the PAADS (psychosis, apathy, agitation, depression, sleep problems) clusters in dementia Rabins, Peter
2013
9 4S p. P2
artikel
339 Basal forebrain atrophy predicts clinical progression in the nondemented elderly Ewers, Michael
2013
9 4S p. P426
artikel
340 Basal forebrain cholinergic system and hippocampus volumes for the prediction of mild cognitive impairment and cortical amyloid accumulation Teipel, Stefan
2013
9 4S p. P408
artikel
341 Baseline FDG-PET and volumetric MRI predicts Alzheimer's disease conversion from mild cognitive impairment: An ADNI study Chen, Kewei
2013
9 4S p. P844
artikel
342 Baseline lipid levels predict cerebral blood flow response to statin therapy in middle-aged adults at risk for Alzheimer's disease Carlsson, Cynthia
2013
9 4S p. P671-P672
artikel
343 Baseline or progression? Biomarkers predictive of memory decline Dodge, Hiroko
2013
9 4S p. P70-P71
artikel
344 Baseline or progression? Biomarkers predictive of memory decline Dodge, Hiroko
2013
9 4S p. P146-P147
artikel
345 Base rates for the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Test Battery Monsch, Andreas
2013
9 4S p. P795
artikel
346 Behavioral, biochemical and imaging characterization of an Alzheimer's disease CVN mouse Ahtoniemi, Toni
2013
9 4S p. P500-P501
artikel
347 Behavioral changes associated with complement C3-deficiency in aged Alzheimer's disease-like Tg mice Shi, Qiaoqiao
2013
9 4S p. P496-P497
artikel
348 Beliefs about Alzheimer's disease and MCI in a community sample of African-Americans Edwards, Dorothy
2013
9 4S p. P478
artikel
349 Beta-amyloid and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease Lim, Yen Ying
2013
9 4S p. P132
artikel
350 Beta-amyloid–associated differential effects of APOE-ε4 on brain metabolism in healthy elderly Yi, Dahyun
2013
9 4S p. P82-P84
artikel
351 Beta-amyloid–associated differential effects of APOE-ε4 on brain metabolism in healthy elderly Yi, Dahyun
2013
9 4S p. P318-P319
artikel
352 Beta-amyloid–induced cell cycle re-entry in Alzheimer's disease is controlled by the Rac1-mTOR pathway Norambuena, Andres
2013
9 4S p. P531-P532
artikel
353 Beta-amyloid–induced neurotoxicity might be reduced through AMPK-mediated by donepezil Park, Moon Ho
2013
9 4S p. P181
artikel
354 Beta-amyloid peptide in the plasma of individuals undergoing plasmapheresis: Effect of age and donation frequency Costa, Montserrat
2013
9 4S p. P858-P859
artikel
355 Beta-arrestin 2 regulates GPCR dysfunction in Alzheimer's disease Thathiah, Amantha
2013
9 4S p. P531
artikel
356 Bexarotene for the treatment of cognitive decline in an individual with Alzheimer's dementia Tousi, Babak
2013
9 4S p. P301
artikel
357 Beyond interest and limits of CSF biomarkers in clinical practice: The PLM study Gabelle, Audrey
2013
9 4S p. P145
artikel
358 Biliverdin reductase-A: A novel drug target for atorvastatin and relevance to statin-mediated reduced risk of developing Alzheimer’s disease Butterfield, D. Allan
2013
9 4S p. P548-P549
artikel
359 Bimodal distribution of the brain beta-amyloid load in the Alzheimer's disease cognitive continuum: Rate of regional accumulation or speed of spatial spread Tosun, Duygu
2013
9 4S p. P843
artikel
360 Binding characterization of novel PET tracer [18F]THK-5117 in the brains of people with Alzheimer's disease Harada, Ryuichi
2013
9 4S p. P276-P277
artikel
361 Binding of cholesterol to the C99 domain of APP competes with homodimerzation of the protein Song, Yuanli
2013
9 4S p. P365
artikel
362 Binswanger-type vascular cognitive impairment no dementia (VCIND) and vascular dementia (VaD) Kwon, Jay
2013
9 4S p. P788-P789
artikel
363 Biochemical analysis of a toxic conformer of beta-amyloid isolated from the brains of people who died with Alzheimer's disease Tomidokoro, Yasushi
2013
9 4S p. P308-P309
artikel
364 Biochemical characterization of native alpha-synuclein derived from cell culture and erythrocytes Liu, Feng
2013
9 4S p. P721
artikel
365 Bioenergetic function is altered prior to disease pathology in a transgenic mouse model of Alzheimer's disease Hascup, Erin
2013
9 4S p. P348
artikel
366 Bioinformatics meets biology: Predicting the role of DNA-sequence variants on micro-RNA function Schilling, Marcel
2013
9 4S p. P178
artikel
367 Biological heterogeneity in ADNI amnestic MCI Nettiksimmons, Jasmine
2013
9 4S p. P222-P223
artikel
368 Biology meets bioinformatics: Validating the predicted role of Alzheimer's GWAS SNPs on micro-RNA function Ansaloni, Sara
2013
9 4S p. P828
artikel
369 Biomarker-based prediction of cognitive decline in 270 nondemented older individuals: Three-year follow-up results from the Australian Imaging Biomarkers and Lifestyle Study of Aging (AIBL) Rowe, Christopher
2013
9 4S p. P12
artikel
370 Biomarker-based prediction of cognitive decline in 270 nondemented older individuals: Three-year follow-up results from the Australian Imaging Biomarkers and Lifestyle study of Aging (AIBL) Rowe, Christopher
2013
9 4S p. P695
artikel
371 Biomarker strategy for enrichment and monitoring of biological effect in ACCTION, a phase II study of ACC-001 (vanutide cridificar) for Alzheimer's disease Margolin, Richard
2013
9 4S p. P289-P290
artikel
372 Blood-based biomarker discovery using aptamer capture (SOMAscan) platform technology Sattlecker, Martina
2013
9 4S p. P861
artikel
373 Blood-based biomarkers of Alzheimer’s disease: Lessons to be learned from studies of cerebrospinal fluid markers Fagan, Anne
2013
9 4S p. P676
artikel
374 Blood-brain barrier permeability observed in rTg4510 tau mouse model Zhang, Bo
2013
9 4S p. P719
artikel
375 Blood-brain-barrier–permeable Hsp90 inhibitor reduces soluble tau burden in a mouse model of Alzheimer's disease Koren, John
2013
9 4S p. P305
artikel
376 Blood epigenetic stratification of Alzheimer's patients Van Eden, Marc
2013
9 4S p. P863
artikel
377 Blood pressure decline in the oldest-old is related to death, not dementia or Alzheimer's disease pathology Corrada, Maria
2013
9 4S p. P754
artikel
378 Body mass and white matter integrity: The role of vascular and inflammatory factors in healthy aging Bettcher, Brianne
2013
9 4S p. P392-P393
artikel
379 Body mass change in Alzheimer's disease Gu, Yian
2013
9 4S p. P206-P207
artikel
380 Both human and rodent ERbeta2 repress estradiol-mediated cell proliferation Wang, Jun Ming
2013
9 4S p. P358
artikel
381 Brain atrophy is associated with decline in activities of daily living after up to 7 years of follow-up Verlinden, Vincentius
2013
9 4S p. P620
artikel
382 BrainCheck: Development of a very short screening instrument for general practitioners combining patient and caregiver information Ehrensperger, Michael
2013
9 4S p. P457
artikel
383 Brain hypoperfusion and neurovascular decoupling in amnestic mild cognitive impairment Zhang, Rong
2013
9 4S p. P775
artikel
384 Brain MAO-B inhibition in healthy elderly and people with Alzheimer's disease after oral administration of RO4602522 Ricci, Benedicte
2013
9 4S p. P667
artikel
385 Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and cerebrospinal fluid biomarkers Binnewijzend, Maja
2013
9 4S p. P684
artikel
386 Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and CSF biomarkers Binnewijzend, Maja
2013
9 4S p. P38
artikel
387 Brains for Dementia Research: Characteristics and cognitive scores associated with the brain tissue available to researchers Hayes, Gillian
2013
9 4S p. P570
artikel
388 Brains for Dementia Research: MMSE profile of the living cohort Hayes, Gillian
2013
9 4S p. P570
artikel
389 Brain white-matter hyperintensity volume is related to lower cognitive function in older community-dwelling individuals without cognitive impairment Arvanitakis, Zoe
2013
9 4S p. P398-P399
artikel
390 BRICHOS efficiently inhibits beta-amyloid 42 aggregation and toxicity in Drosophila melanogaster Hermansson, Erik
2013
9 4S p. P125-P126
artikel
391 Burden, family adaptability-cohesion, devotion and depression of dementia caregivers Eun, Hun Jeong
2013
9 4S p. P483
artikel
392 Butyrylcholinesterase-associated neuropathology in early-onset familial Alzheimer's disease Darvesh, Sultan
2013
9 4S p. P432-P433
artikel
393 Calcium channel blockers commonly used as antihypertension agents augment the deleterious effect of beta-amyloid peptides on cells Lin, Ho-pi
2013
9 4S p. P182
artikel
394 Calibration of a new approach for estimating general cognitive performance for GWAS of cognitive decline in Alzheimer's disease Gross, Alden
2013
9 4S p. P697-P698
artikel
395 Calorie restriction, but not ketogenic diet, improves cognition in mouse models of Alzheimer's pathology Brownlow, Milene
2013
9 4S p. P160
artikel
396 Can abnormal glucose metabolism lead to the Alzheimer's disease pathologies? Gibson, Gary
2013
9 4S p. P825
artikel
397 Canada-China Cohort Study of early-onset familial Alzheimer's disease Gauthier, Serge
2013
9 4S p. P204
artikel
398 Candidate blood proteome markers of Alzheimer's disease onset and progression: A systematic review and replication study Bazenet, Chantal
2013
9 4S p. P857-P858
artikel
399 Can near infrared spectroscopy be used for early detection and diagnosis of brain microvascular disease? Troen, Aron
2013
9 4S p. P836
artikel
400 Capacity to vote in dementia patients and in healthy elderly Greek population Tsolaki, Magda
2013
9 4S p. P472
artikel
401 Capgras-like visual decomposition in Lewy body dementia (LBD) with therapeutic response to donepezil: Two clinical cases with neuropsychological and neuroimaging correlates Reimers, Karen
2013
9 4S p. P866
artikel
402 Capgras syndrome associated with Parkinson's disease dementia: Report of two cases Apaydin, Hulya
2013
9 4S p. P733-P734
artikel
403 Capillary dysfunction in Alzheimer's disease Østergaard, Leif
2013
9 4S p. P269-P270
artikel
404 Cardiovascular risk factors for cognitive function: Effects from early adulthood to mid-life Yaffe, Kristine
2013
9 4S p. P135
artikel
405 Cardiovascular risk factors in transient global amnesia: A case control study from 293 participants Jang, Jae-Won
2013
9 4S p. P383-P384
artikel
406 Caregiver Burden Scale item analysis: Implications for mental health counseling approaches Shaw, Edward
2013
9 4S p. P646
artikel
407 Caregiver prediction of road test performance Carr, David
2013
9 4S p. P849
artikel
408 Caregivers and medicines: The untold story in dementia Maidment, Ian
2013
9 4S p. P481
artikel
409 Caregivers can recognize therapeutic effects from improvements in dementia patients' volition and activity Matsumura, Miyuki
2013
9 4S p. P887-P888
artikel
410 Care management for VA patients with vascular risk factors and cognitive impairment: A randomized trial Bonner, Laura M.
2013
9 4S p. P526-P527
artikel
411 Care of people with Alzheimer's disease in the Middle East Abyad, Abdulrazak
2013
9 4S p. P646
artikel
412 Caring for an older adult with bipolar disorder is subject to greater burden than caring for dementia Santos, Glenda
2013
9 4S p. P487
artikel
413 Case management for patients with dementia in primary care: Why it doesn't work—A mixed studies systematic review Khanassov, Vladimir
2013
9 4S p. P116
artikel
414 Caspase cleavage of tau is critical for oligomeric beta-amyloid–induced sub-lethal apoptotic cascade Polydoro, Manuela
2013
9 4S p. P568-P569
artikel
415 Cathepsin B produces brain pyro-glu-beta-amyloid in a transgenic Alzheimer's disease mouse model Hook, Vivian
2013
9 4S p. P143
artikel
416 CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease Caccamo, Antonella
2013
9 4S p. P187
artikel
417 Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease in the National Alzheimer's Coordinating Center Neuropathology data set Brenowitz, Willa
2013
9 4S p. P433
artikel
418 Cerebral amyloid angiopathy-associated vasculopathy and apolipoprotein E accumulation after beta-amyloid immunotherapy for Alzheimer's disease Nicoll, James
2013
9 4S p. P529
artikel
419 Cerebral amyloid angiopathy in Alzheimer’s disease is associated with increased blood-brain barrier permeability: A quantitative [11C]PiB-PET study van Berckel, Bart
2013
9 4S p. P130
artikel
420 Cerebral amyloid angiopathy in Alzheimer’s disease is associated with increased blood-brain barrier permeability: A quantitative [11C]PiB-PET study van Berckel, Bart
2013
9 4S p. P12-P13
artikel
421 Cerebral amyloid angiopathy in a multicenter cohort of people with MCI and Alzheimer's disease Enderlé, Adeline
2013
9 4S p. P424
artikel
422 Cerebral amyloid-associated changes in brain perfusion in autosomal dominant Alzheimer's disease Kim, Albert
2013
9 4S p. P874
artikel
423 Cerebral blood flow measured by arterial spin labeling magnetic resonance imaging: Regional reductions in early stages of Alzheimer's disease and comparisons with brain volume loss Mattsson, Niklas
2013
9 4S p. P589
artikel
424 Cerebral glucose metabolism, pathology and behavior in the 5XFAD mouse model of Alzheimer's disease Macdonald, Ian
2013
9 4S p. P32
artikel
425 Cerebral glucose metabolism, pathology and behaviour in the 5XFAD mouse model of Alzheimer's disease Macdonald, Ian
2013
9 4S p. P246
artikel
426 Cerebral microbleeds and the risk of mortality in the general population Akoudad, Saloua
2013
9 4S p. P80
artikel
427 Cerebral microbleeds and the risk of mortality in the general population Akoudad, Saloua
2013
9 4S p. P408-P409
artikel
428 Cerebral microbleeds are related to loss of white matter structural integrity Akoudad, Saloua
2013
9 4S p. P130
artikel
429 Cerebral microbleeds are related to loss of white matter structural integrity Akoudad, Saloua
2013
9 4S p. P80
artikel
430 Cerebral white matter hyperintensities in the prediction of incident dementia and mild cognitive impairment: Which determinants modulate this association? Mortamais, Marion
2013
9 4S p. P843-P844
artikel
431 Cerebrospinal fluid beta-amyloid 42, tau, phosphorylated tau 181, and resting state functional connectivity Wang, Liang
2013
9 4S p. P405-P406
artikel
432 Cerebrospinal fluid beta-amyloid 42, tau, ptau181 and resting state functional connectivity Wang, Liang
2013
9 4S p. P68-P69
artikel
433 Cerebrospinal fluid biomarkers and PET imaging of cerebral glucose metabolism in Iraq and Afghanistan veterans: Converging evidence of brain dysfunction and neurodegeneration Peskind, Elaine
2013
9 4S p. P229
artikel
434 Cerebrospinal fluid biomarkers for preclinical Alzheimer’s disease: Results from an 18-year follow-up of women in Gothenburg Skoog, Ingmar
2013
9 4S p. P682
artikel
435 Cerebrospinal fluid biomarkers in clinical subtypes of early-onset Alzheimer's disease Teng, Edmond
2013
9 4S p. P370
artikel
436 Cerebrospinal fluid biomarkers in dementia with Lewy bodies Honig, Lawrence
2013
9 4S p. P372
artikel
437 Cerebrospinal fluid chemokine levels in healthy older adults: Relationship to beta-amyloid and tau indices Pomara, Nunzio
2013
9 4S p. P232
artikel
438 Cerebrospinal fluid (CSF) biomarkers Schlossmacher, Michael
2013
9 4S p. P311
artikel
439 Cerebrospinal fluid tau levels increase with age and are associated with neurodegeneration even in the absence of cerebral amyloid Dickerson, Brad
2013
9 4S p. P699
artikel
440 Cerebrospinal heart fatty-acid–binding protein as a biomarker for Alzheimer's disease Cruchaga, Carlos
2013
9 4S p. P705
artikel
441 Cerebrovascular amyloid: Evidence from the Honolulu-Asia Aging Study suggesting two distinct underlying pathogenic processes White, Lon
2013
9 4S p. P192
artikel
442 Cerebrovascular and Alzheimer's disease: A synergistic pathogenesis Goos, Jeroen
2013
9 4S p. P332
artikel
443 Cerebrovascular disease and higher prevalence of dementia in individuals with fewer years of education: A neuropathological study Nitrini, Ricardo
2013
9 4S p. P441-P442
artikel
444 Challenges in health care for people with dementia in Ghana Spittel, Susanne
2013
9 4S p. P488
artikel
445 Challenges in international clinical trials to delay early symptomatic Alzheimer's disease Welsh-Bohmer, Kathleen
2013
9 4S p. P137-P138
artikel
446 Change in cognition over 36 months in relation to blood biomarkers Zhang, Ping
2013
9 4S p. P204
artikel
447 Changes in calcium-related gene expression consistent with Alzheimer's disease are initiated by infection of neuronal cells with Chlamydia pneumoniae Appelt, Denah
2013
9 4S p. P192
artikel
448 Changes in cerebral vascular reactivity in elderly with mild cognitive impairment: Vascular case-control study Mimenza, Alberto
2013
9 4S p. P769-P770
artikel
449 Changes in dementia diagnostic category and diagnostic confidence following dopamine transporter SPECT imaging (DaTscanTM - Ioflupane 123I) in people with an uncertain diagnosis of dementia with Lewy bodies (possible DLB) Walker, Zuzana
2013
9 4S p. P379
artikel
450 Changes in dementia risk factors over 40 years: Experiences from Finland Solomon, Alina
2013
9 4S p. P511-P512
artikel
451 Changing attitudes toward dementia in family practice Vollmar, Horst Christian
2013
9 4S p. P885
artikel
452 Characteristics associated with willingness to participate in technology-based behavioral clinical trials Dodge, Hiroko
2013
9 4S p. P475-P476
artikel
453 Characteristics in logopenic variant primary progressive aphasia with PiB-PET–positive patients Yoon, Soo Jin
2013
9 4S p. P538-P541
artikel
454 Characteristics in logopenic variant primary progressive aphasia with PiB-PET-positive patients Yoon, Soo Jin
2013
9 4S p. P820-P823
artikel
455 Characteristics of people misdiagnosed with Alzheimer's disease and their medication use: An analysis of the National Alzheimer's Coordinating Center Uniform Data Set database Ascher-Svanum, Haya
2013
9 4S p. P734
artikel
456 Characterization of a novel monoclonal antibody specific for a tau autoproteolytic cut site that differentiates between Alzheimer's disease and non-Alzheimer's specimens Davidowitz, Eliot
2013
9 4S p. P308
artikel
457 Characterization of a seed-competent tau species in a cell-based model of tauopathy Jackson, Samuel
2013
9 4S p. P719
artikel
458 Characterization of a transgenic model of Alzheimer's disease: The influence of Npas4 gene expression on the development of the pathology Duran, Jorge
2013
9 4S p. P556
artikel
459 Characterization of beta-amyloid 1-40 across species following treatment with beta-secretase inhibitors Robshaw, Ashley
2013
9 4S p. P502
artikel
460 Characterization of cortical electroencephalographic (EEG) rhythms in three transgenic mouse strains that develop Alzheimer's disease-associated neuropathological features Kelley, Jonathan
2013
9 4S p. P499
artikel
461 Characterization of cortical microstructural changes in Alzheimer's disease Gordon, Brian
2013
9 4S p. P279
artikel
462 Characterization of cortical microstructural changes in Alzheimer's disease Gordon, Brian
2013
9 4S p. P60
artikel
463 Characterization of double transgenic mice, APPSLxhQC, exhibiting enhanced pyroGlu3-beta-amyloid formation to evaluate efficacy of glutaminyl cyclase (QC) inhibitors Schilling, Stephan
2013
9 4S p. P328
artikel
464 Characterization of [F-18]FIBT, a highly selective and specific PET imaging agent for beta-amyloid plaques Yousefi, Behrooz Hooshyar
2013
9 4S p. P336-P337
artikel
465 Characterization of regional cerebral blood flow in mild cognitive impairment and older adults with cognitive complaints Wang, Yang
2013
9 4S p. P71
artikel
466 Characterization of regional cerebral blood flow in people with mild cognitive impairment and older adults with cognitive complaints Wang, Yang
2013
9 4S p. P276
artikel
467 Characterizing eye movement as a predictor of cognitive decline: Applying machine learning to improve prediction accuracy Lagun, Dmitry
2013
9 4S p. P462-P463
artikel
468 Characterizing inflammatory components in human Alzheimer's disease and following active beta-amyloid 42 immunization Boche, Delphine
2013
9 4S p. P283-P284
artikel
469 Characterizing the Alzheimer's disease prefrontal cortex transcriptome by multiple RNA-sequencing Ryvkin, Paul
2013
9 4S p. P574
artikel
470 Characterizing the effect of Alzheimer's disease on everyday motion behavior Dyrba, Martin
2013
9 4S p. P787
artikel
471 Characterizing the role of MICRO-RNA expression in the aging human brain transcriptome Rajagopal, Sathyapriya
2013
9 4S p. P828
artikel
472 Characterizing upregulated miRNAs during preclinical prion disease: Possible role in neuroprotection Majer, Anna
2013
9 4S p. P359
artikel
473 Choice of ADNI MPRAGE volume and RF coil affects brain segmentation comparability Brunton, Simon
2013
9 4S p. P428-P429
artikel
474 Cholesterol metabolites as endogenous gamma-secretase modulators Felsenstein, Kevin
2013
9 4S p. P121-P122
artikel
475 Cholinergic dysregulation in prodromal Alzheimer’s disease Mufson, Elliott
2013
9 4S p. P514
artikel
476 Chronic BACE1 inhibition reduces pre-existing parenchymal amyloid plaque load in the brain of a mouse model of Alzheimer's disease Pan, Feng
2013
9 4S p. P504
artikel
477 Chronic ponezumab treatment reduces brain vascular amyloid in the PS1APP mouse model O'Neill, Sharon
2013
9 4S p. P814
artikel
478 Chronic treatment with a CNTF-derived peptide reverses dendritic and synaptic plasticity deficits, cognitive impairment and tau pathology in an Alzheimer's disease mouse model Kazim, Syed Faraz
2013
9 4S p. P548
artikel
479 Chronic treatment with scyllo-inositol reduces brain myo-inositol levels and enhances performance in a rat model of social withdrawal Shughrue, Paul
2013
9 4S p. P157
artikel
480 Circadian activity rhythm patterns in nondemented older women and cognitive function 5 years later Walsh, Christine
2013
9 4S p. P608
artikel
481 Circadian rhythms in cognitive functioning: Impact on signal detection in clinical trials of pro-cognitive therapies Hufford, Michael
2013
9 4S p. P298
artikel
482 Circulating miRNA biomarkers for Alzheimer's disease Kumar, Pavan
2013
9 4S p. P238
artikel
483 Citalopram decreases acute CSF beta-amyloid concentration in young, healthy study participants Sheline, Yvette
2013
9 4S p. P728-P729
artikel
484 CKII recruited by 14-3-3ζ promotes SET phosphorylation Xia, Yi-Yuan
2013
9 4S p. P363
artikel
485 Clearance of beta-amyloid protofibrils/oligomers in the brain and CSF of TG-APP ARCSWE mice following treatment with the protofibril-selective antibody mAb158 Tucker, Stina
2013
9 4S p. P506
artikel
486 Clinical adherence of taking donepezil in mild-to-moderate Alzheimer's disease in Taiwan Chang, Yun-Ping
2013
9 4S p. P883-P884
artikel
487 Clinical adherence of taking memantine in moderate-to-severe Alzheimer's disease in Taiwan Tseng, I-Chun
2013
9 4S p. P881
artikel
488 Clinical adherence of taking rivastigmine in mild-to-moderate Alzheimer's disease in Taiwan Wang, Cheng-Kang
2013
9 4S p. P891
artikel
489 Clinical and economic burden of Alzheimer's disease in the United States and in Europe Takizawa, Claire
2013
9 4S p. P464-P465
artikel
490 Clinical and neurocognitive features of early Dementia with Lewy Bodies (DLB) Ferman, Tanis
2013
9 4S p. P311
artikel
491 Clinical and neuropsychological features as predictors from MCI to Alzheimer’s-type dementia van Rossum, Ineke
2013
9 4S p. P122
artikel
492 Clinical applicability of new criteria for MCI due to Alzheimer's disease and vascular MCI Prins, Niels
2013
9 4S p. P767
artikel
493 Clinical benefits of extended-release memantine (28 mg, once daily) as a function of disease severity in people with moderate to severe Alzheimer's disease: Post hoc analysis from a randomized trial Tocco, Michael
2013
9 4S p. P655
artikel
494 Clinical characteristics of people with early-onset Alzheimer's disease: A Clinical Research Center for Dementia of South Korea study Park, Hee Kyung
2013
9 4S p. P749
artikel
495 Clinical correlates of hippocampal sclerosis of aging: The University of Kentucky experience Nelson, Peter
2013
9 4S p. P773
artikel
496 Clinical course of Lewy-body disease: Cognitive decline and mortality Østerhus, Ragnhild Djønne
2013
9 4S p. P537-P538
artikel
497 Clinical dementia rating modeling and simulation: Modeling and simulation of CDR progression in the ADNI cohort based on item response theory Polhamus, Daniel
2013
9 4S p. P668
artikel
498 Clinical diagnosis and care of dementia: Why it matters (includes introduction to case studies) Borson, Soo
2013
9 4S p. P1
artikel
499 Clinical gamma-secretase inhibitors (GSIs) alter beta-amyloid 40/42 ratio in brain and show CSF beta-amyloid rebound in vivo Nolan, Charles
2013
9 4S p. P806-P807
artikel
500 Clinical, pathologic and genetic associations of TDP-43 pathology in Alzheimer's disease Kofler, Julia
2013
9 4S p. P436
artikel
501 Clinical study of E2609, a novel BACE1 inhibitor, demonstrates target engagement and inhibition of BACE1 activity in CSF Bernier, Francois
2013
9 4S p. P886
artikel
502 Clinical utility of the cogstate brief battery in Alzheimer's disease–related memory impairment Maruff, Paul
2013
9 4S p. P636-P637
artikel
503 Clinician and caregiver prediction of driving competence in older adults who may have early Alzheimer's disease: Validation with road tests and naturalistic driving assessments Davis, Jennifer
2013
9 4S p. P473
artikel
504 Clinicopathological study of frontotemporal dementia with homozygous mutation of the C9ORF72 gene Lashley, Tammaryn
2013
9 4S p. P437
artikel
505 Clock drawing as a screen for impaired driving in aging and dementia: Is it worth the time? Manning, Kevin
2013
9 4S p. P475
artikel
506 Clusterin: An early biomarker for Alzheimer's disease? van Dijk, Karin
2013
9 4S p. P198-P199
artikel
507 Clusterin associates specifically with beta-amyloid 40 Alzheimer's disease brain tissue Francis, Paul
2013
9 4S p. P576
artikel
508 CNTN5 and ARID5B are associated with enthorinal cortex volume and thickness in healthy individuals in several ethnic groups Tosto, Giuseppe
2013
9 4S p. P706
artikel
509 Coenzyme Q10 restores amyloid beta-inhibited proliferation of neural stem cells by activating the PI3K pathway Choi, Hojin
2013
9 4S p. P568
artikel
510 Cognition, cortical thickness and hippocampal shape in pure vascular mild cognitive impairmentand dementia Kim, Hee-Jin
2013
9 4S p. P599-P600
artikel
511 Cognitive and behavioral features of African-Americans carrying the rs45455403 miRNA polymorphism Kumar, Anand
2013
9 4S p. P172-P173
artikel
512 Cognitive and clinical outcomes after handheld-computer cognitive training in people with mild cognitive impairment Hsiung, Ging-Yuek
2013
9 4S p. P456-P457
artikel
513 Cognitive and neural substrates of learning impairment in prodromal Alzheimer's disease Jonin, Pierre-Yves
2013
9 4S p. P537
artikel
514 Cognitive and physical contributions to activities of daily living Wong, Bonnie
2013
9 4S p. P762-P763
artikel
515 Cognitive behavioral therapy to enhance cognitive rehabilitation efficacy in Alzheimer's disease Fane, Megan
2013
9 4S p. P495
artikel
516 Cognitive changes following oophorectomy Au, April
2013
9 4S p. P877
artikel
517 Cognitive characteristics of subcortical vascular dementia Kwon, Oh Dae
2013
9 4S p. P792
artikel
518 Cognitive composite development for mild cognitive impairment (MCI) using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Hendrix, Suzanne
2013
9 4S p. P892
artikel
519 Cognitive consequences of high beta-amyloid levels in people with mild cognitive impairment and healthy older adults: Implications for early detection of Alzheimer's disease Lim, Yen Ying
2013
9 4S p. P446
artikel
520 Cognitive correlates of cholinergic basal forebrain atrophy and associated cortical hypometabolism in mild cognitive impairment Grothe, Michel
2013
9 4S p. P261
artikel
521 Cognitive correlates of striatal amyloid deposition in preclinical and early autosomal dominant Alzheimer's disease Snitz, Beth
2013
9 4S p. P879
artikel
522 Cognitive decline, neural function and amyloid burden in middle-aged adults at risk for Alzheimer’s disease: Findings from the Wisconsin Registry for Alzheimer's Prevention Okonkwo, Ozioma
2013
9 4S p. P45
artikel
523 Cognitive decline, neural function and amyloid burden in middle-aged adults at risk for Alzheimer's disease: Findings from the Wisconsin Registry for Alzheimer's Prevention (WRAP) Okonkwo, Ozioma
2013
9 4S p. P317-P318
artikel
524 Cognitive difficulties as a patient-reported outcome for older adults with normal cognition, MCI or mild Alzheimer's disease Karlawish, Jason
2013
9 4S p. P639
artikel
525 Cognitive disorders management in Latin America: More therapies, less drugs Santiago, O'Neill
2013
9 4S p. P492
artikel
526 Cognitive evidence in people with Alzheimer's disease that compromised hippocampal neurogenesis is related both to APOE-ɛ4 status and CSF beta-amyloid 42 Wesnes, Keith
2013
9 4S p. P748
artikel
527 Cognitive functions and CSF biomarkers in MCI: Preliminary findings of follow-up study Mandecka, Monika
2013
9 4S p. P220-P221
artikel
528 Cognitive impairment affects mortality in Japan: The Tajiri Project 1991-2005 Meguro, Kenichi
2013
9 4S p. P631
artikel
529 Cognitive impairment correlated with vitamin D deficiency in the elderly with severe comorbidities Trang, Phuong
2013
9 4S p. P889-P890
artikel
530 Cognitive impairment in moderate chronic kidney disease: The brain in kidney disease (BRINK) study Stendahl, John
2013
9 4S p. P388
artikel
531 Cognitive impairment in neurosyphilis: Alzheimer's disease-like pattern? Topcular, Baris
2013
9 4S p. P752
artikel
532 Cognitive performance of demented, depressed patients with cardiovascular pathology with and without diabetes mellitus: A preliminary report of a cross-sectional study Bragin, Valentin
2013
9 4S p. P759
artikel
533 Cognitive profiles of frontotemporal dementia and Alzheimer's disease in a Colombian sample: A preliminary investigation Quiroz, Yakeel
2013
9 4S p. P791
artikel
534 Cognitive reserve benefits brain efficiency in healthy aging Cabranes, Jose Antonio
2013
9 4S p. P383
artikel
535 Cognitive reserve modulates neural responses in subjective and mild cognitive impairment Cecchetti, Luca
2013
9 4S p. P490
artikel
536 Cognitive variability as a potential biomarker for incident mild cognitive impairment and Alzheimer's disease: An ADNI data analysis Wahoske, Michelle
2013
9 4S p. P863
artikel
537 CogState computerized testing is associated with amyloid and FDG-PET: Implications for secondary preventive trials Mielke, Michelle
2013
9 4S p. P24
artikel
538 Collaboration for a systematic comparison of different techniques to measure subfield volumes: Announcement and first results Mueller, Susanne
2013
9 4S p. P51
artikel
539 Collection of data for elderly drivers without dementia during simulated driving Kawano, Naoko
2013
9 4S p. P475
artikel
540 Combination of ZSET1446 (ST101) with galantamine, rivastigmine or memantine synergistically ameliorates cognitive function mediated by increase in the extracellular level of acetylcholine Yamaguchi, Yoshimasa
2013
9 4S p. P816
artikel
541 Combinations of amyloid and neurodegeneration biomarkers have a differential impact on cognition Knopman, David
2013
9 4S p. P682-P683
artikel
542 Combined nutrient supplementation enhances neurite outgrowth and synaptic protein expression in vitro Savelkoul, Paul
2013
9 4S p. P359-P360
artikel
543 Combining morphometric measurements of the basal forebrain cholinergic system and cortical thickness for better diagnostic accuracy Kilimann, Ingo
2013
9 4S p. P97
artikel
544 Combining morphometric measurements of the basal forebrain cholinerigc system and the cortical thickness for better diagnostic accuracy Kilimann, Ingo
2013
9 4S p. P405
artikel
545 Combining white matter density and atrophy information to improve the characterization of axonal loss in Alzheimer's disease Raffelt, David
2013
9 4S p. P87-P88
artikel
546 Combining white matter density and atrophy information to improve the characterization of axonal loss in Alzheimer's disease Raffelt, David
2013
9 4S p. P277
artikel
547 Common rater errors when scoring the ADAS-Cog Perez, Magdalena
2013
9 4S p. P472
artikel
548 Communication skills training for care staff: Supporting quality care for people with dementia living in the community Conway, Erin
2013
9 4S p. P340-P341
artikel
549 Comparative study of the uses of grammatical categories: Adjectives, adverbs, pronouns, interjections, conjunctions and prepositions in patients with Alzheimer's disease Alegria, Renne
2013
9 4S p. P882
artikel
550 Comparative study of white matter integrity between mild Alzheimer's dementia and mild cognitive impairment Joshi, Himanshu
2013
9 4S p. P425-P426
artikel
551 Comparing neuropsychiatric symptoms in patients with Alzheimer's disease and vascular dementia Saund, Amardeep
2013
9 4S p. P525-P526
artikel
552 Comparing the Memory Impairment Screen (MIS) test with the Memory Impairment Screen Deferred (MISD) for detection of amnestic mild cognitive impairment (aMCI) Labos, Edith
2013
9 4S p. P445-P446
artikel
553 Comparison between eicosapentaenoic and docosahexaenoic acids in an animal model of Alzheimer's disease Lebbadi, Meryem
2013
9 4S p. P507
artikel
554 Comparison between pure Alzheimer's disease and Alzheimer's disease with mild parkinsonian sign Kim, Hee-Jin
2013
9 4S p. P384
artikel
555 Comparison of accelerated and nonaccelerated MRI in ADNI: Effects on measures of brain and ventricular volumes and rates of atrophy Leung, Kelvin
2013
9 4S p. P585-P587
artikel
556 Comparison of accelerated and nonaccelerated MRI in ADNI: Effects on measures of brain and ventricular volumes and rates of atrophy Leung, Kelvin
2013
9 4S p. P89-P90
artikel
557 Comparison of amyloid profiles using CSF and cortical florbetapir-PET imaging in prodromal Alzheimer's disease Saint-Aubert, Laure
2013
9 4S p. P830
artikel
558 Comparison of auditory P300 responses in healthy elderly, people with mild cognitive impairment and people with Alzheimer's disease Emek, Derya Durusu
2013
9 4S p. P229
artikel
559 Comparison of automated segmentation of intracranial volume between 3D-T1 and 3D-T2 sequences Bracoud, Luc
2013
9 4S p. P98
artikel
560 Comparison of automated segmentation of intracranial volume between 3D T1 and 3D T2 sequences Bracoud, Luc
2013
9 4S p. P270
artikel
561 Comparison of cortical thickness between Koreans and Western individuals with mild cognitive impairment Kim, Seong Yoon
2013
9 4S p. P71-P72
artikel
562 Comparison of 11C-PiB-PET, FDG-PET and MRI modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia Hochstetler, Helen
2013
9 4S p. P408
artikel
563 Comparison of [18F] flutemetamol beta-amyloid imaging with [11C] PiB across the spectrum of Alzheimer's disease Hatashita, Shizuo
2013
9 4S p. P419
artikel
564 Comparison of florbetapir positron emission tomography scans with cerebrospinal fluid biomarkers in healthy individuals and people with mild cognitive impairment or Alzheimer's disease dementia Hake, Ann
2013
9 4S p. P591
artikel
565 Comparison of local grey matter volume in familial and sporadic Alzheimer's disease Cash, David
2013
9 4S p. P426-P427
artikel
566 Comparison of local grey matter volume in familial and sporadic Alzheimer's disease Cash, David
2013
9 4S p. P45-P46
artikel
567 Comparison of manual and automated multi-atlas hippocampal volume measurements in the University of California, Davis, Alzheimer's Disease Center cohort Schaerer, Joël
2013
9 4S p. P97-P98
artikel
568 Comparison of manual and automated multi-atlas hippocampal volume measurements in the University of California-Davis Alzheimer's Disease Center patient cohort Schaerer, Joël
2013
9 4S p. P273
artikel
569 Comparison of Montreal Cognitive Assessment (MoCA) and 3MSE scores in African-Americans Sink, Kaycee
2013
9 4S p. P321
artikel
570 Comparison of PiB-PET data to florbetapir-PET data acquired from cohorts at different research sites Chiotis, Konstantinos
2013
9 4S p. P275
artikel
571 Comparison of PiB-PET data to florbetapir-PET data acquired from different patient cohorts at different research sites Chiotis, Konstantinos
2013
9 4S p. P13
artikel
572 Comparison of rural and urban dementia prevalences in two countries of Central Africa: The EPIDEMCA Study Guerchet, Maëlenn
2013
9 4S p. P688
artikel
573 Comparison of surrogate matrix and surrogate analyte approaches for quantifying beta-amyloid peptides in human cerebrospinal fluid using LC-MS/MS methods Jenkins, Rand
2013
9 4S p. P216
artikel
574 Comparison of the nutritional status of residents in shared-housing arrangements and nursing homes Wolf-Ostermann, Karin
2013
9 4S p. P606
artikel
575 Comparison of the structures of gamma-secretase substrates notch and C99-APP Deatherage, Catherine
2013
9 4S p. P365-P366
artikel
576 Complement C3-deficiency preserves hippocampal synapses and neurons with aging and improves learning and memory compared to WT mice Lemere, Cynthia
2013
9 4S p. P328
artikel
577 Complexes of beta-amyloid peptides and of intracellular proteins in cerebrospinal fluid: New biomarkers of Alzheimer's disease? Ripova, Daniela
2013
9 4S p. P197
artikel
578 Complex expression of BDNF and reelin in the developing and adult brain of TgCRND8 mice Fuso, Andrea
2013
9 4S p. P357
artikel
579 Compounds in exhaled air for the detection of Alzheimer's disease Bach, Jan-Philipp
2013
9 4S p. P226
artikel
580 Comprehensive analysis of glycosylation patterns of human plasma clusterin: A putative PTM marker of Alzheimer's disease Russell, Claire
2013
9 4S p. P237
artikel
581 Compromised nutrient uptake and metabolism in Alzheimer's disease: Possible implications for nutritional management of Alzheimer's disease Sijben, John
2013
9 4S p. P605
artikel
582 Computer-based adverse drug effects monitoring systems and the impact on patients' outcomes: A literature overview Gräske, Johannes
2013
9 4S p. P649-P650
artikel
583 Concordance between CSF biomarkers and [11C]PIB PET in a memory clinic population Zwan, Marissa
2013
9 4S p. P830
artikel
584 Concordance between CSF biomarkers and [11C]PiB-PET in a memory clinic population Zwan, Marissa
2013
9 4S p. P13
artikel
585 Concurrent validity of Dubois' five-word-test compared with CERAD memory subtests Damian, Marinella
2013
9 4S p. P463
artikel
586 Consensus diagnosis and predictors of diagnostic accuracy in the national Alzheimer's Disease Centers Bristow, Katherine
2013
9 4S p. P321
artikel
587 Consequences of beta-amyloid immunotherapy for Alzheimer's disease on neurons in the human cerebral cortex Boche, Delphine
2013
9 4S p. P284
artikel
588 Consistency of BACE inhibitor-mediated brain amyloid production inhibition by MK-8931 in Alzheimer’s disease patients and healthy young adults Stone, Julie
2013
9 4S p. P690-P691
artikel
589 Construct validity of MoCA subscales across community-based registries, from North Carolina to Tomsk, Russia Hayden, Kathleen
2013
9 4S p. P849-P850
artikel
590 Contents 2013
9 4S p. A2-A5
artikel
591 Contribution of Alzheimer's disease and Lewy body pathology to behavior and cognition in Lewy body dementias Francis, Paul
2013
9 4S p. P566
artikel
592 Conversion to MCI and amyloid-positivity in normal controls Klunk, William
2013
9 4S p. P150
artikel
593 Conversion to MCI in healthy individuals with abnormal CSF Aβ42 levels is associated with specific longitudinal morphological changes of the brain Lorenzi, Marco
2013
9 4S p. P596
artikel
594 Conversion to MCI in healthy individuals with abnormal CSF beta-amyloid 42 levels is associated with specific longitudinal morphological changes of the brain Lorenzi, Marco
2013
9 4S p. P47-P48
artikel
595 Coping and positive aspects of caregiving: A cross-cultural study of Chinese dementia caregivers in Phoenix and their counterparts in Shanghai Sun, Fei
2013
9 4S p. P324
artikel
596 Correcting bias in estimates of differential rates of cognitive decline caused by informative missing data through the use of telephone cognitive evaluations Hall, Charles
2013
9 4S p. P697
artikel
597 Correction of scanner differences in multicenter J-ADNI and U.S.-ADNI PET studies Fujiwara, Ken
2013
9 4S p. P262
artikel
598 Correlates of subjective and mild cognitive impairment Grambaite, Ramune
2013
9 4S p. P877
artikel
599 Correlation between autophagy and cognitive impairment in people with Alzheimer's disease Jia, Jianping
2013
9 4S p. P194
artikel
600 Correlation between CpG DNA methylation levels in peripheral CD4+ T cells and dorsal lateral prefrontal cortex tissue Rosenkrantz, Laura
2013
9 4S p. P573
artikel
601 Correlation of brain atrophy with clinical progression in mild-to-moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab Novak, Gerald
2013
9 4S p. P289
artikel
602 Correlation of brain structural and functional changes in amnestic mild cognitive impairment and mild Alzheimer's disease: A voxel-by-voxel analysis in a single cohort of patients in Brazil Coutinho, Artur
2013
9 4S p. P72
artikel
603 Correlation of cognitive functioning with regional volumetric measurements and diffusion tensor images assessed by brain magnetic resonance imaging Demey, Ignacio
2013
9 4S p. P785
artikel
604 Correlation of 18F-FDG PET findings with neuropsychological results in posterior cortical atrophy and typical Alzheimer's disease Kim, Byeong C.
2013
9 4S p. P382-P383
artikel
605 Correlation study between genetic risk factors and leukoariosis in people with dementia Kang, Heeyoung
2013
9 4S p. P171
artikel
606 Cortical beta-amyloid and microstructural properties of the corpus callosum in people with mild-to-moderate Alzheimer's disease Frederiksen, Kristian Steen
2013
9 4S p. P382
artikel
607 Cortical beta-amyloid and microstructural properties of the corpus callosum in people with mild-to-moderate Alzheimer’s disease Frederiksen, Kristian Steen
2013
9 4S p. P14
artikel
608 Cortical laminar analysis of beta-amyloid deposition, astrogliosis and neuronal density in a mouse model of Alzheimer's disease Ho, Ming-Kai
2013
9 4S p. P33
artikel
609 Cortical laminar analysis of beta-amyloid deposition, astrogliosis and neuronal density in a mouse model of Alzheimer's disease Ho, Ming-Kai
2013
9 4S p. P247-P248
artikel
610 Cortical neural synchronization mechanisms in Alzheimer's disease as revealed by resting state EEG rhythms: A window on cholinergic function? Babiloni, Claudio
2013
9 4S p. P515
artikel
611 Cortical surface projection of PET images from 11C- and 18F-labeled radiotracers without magnetic resonance imaging Doré, Vincent
2013
9 4S p. P263-P264
artikel
612 Cortical thinning in subjective memory impairment Meiberth, Dix
2013
9 4S p. P73-P74
artikel
613 Cortical thinning in subjective memory impairment Meiberth, Dix
2013
9 4S p. P410-P411
artikel
614 Cortisol and TNF-soluble receptor levels and 1-year cognitive and functional performance in a community-based sample of the oldest Brazilian elderly: The Pietà Study Guimarães, Henrique
2013
9 4S p. P207-P208
artikel
615 COSMIC: COhort Studies of Memory in an International Consortium Sachdev, Perminder
2013
9 4S p. P611
artikel
616 Cost-effective strategies in creating dementia awareness: A Cochin experience Kuriakose, Jacob Roy
2013
9 4S p. P647
artikel
617 Critical role of death-associated protein kinase 1 for the regulation of tau function Kim, Byeong Mo
2013
9 4S p. P718-P719
artikel
618 Cross-inhibition of beta-amyloid plaque formation by alpha-synuclein Bachhuber, Teresa
2013
9 4S p. P708-P709
artikel
619 Cross-sectional clinical, neuropsychological, neuroimaging, neurophysiological and biochemical characterization of people with mild cognitive impairment in the WP5 PharmaCog/E-ADNI study Babiloni, Claudio
2013
9 4S p. P48
artikel
620 Cross-sectional clinical, neuropsychological, neuroimaging, neurophysiological and biochemical characterization of people with mild cognitive impairment in WP5 pharmacog/E-ADNI study Babiloni, Claudio
2013
9 4S p. P205
artikel
621 Cross-sectional, longitudinal and laterality measures of hippocampus, parahippocampus and entorhinal cortex in mild cognitive impairment Brunton, Simon
2013
9 4S p. P430
artikel
622 Cross-species analysis of cerebrospinal fluid (CSF) beta-amyloid reductions by the BACE1 inhibitor PF-05297909 indicates species differences in PK/PD relationships: Relevance to clinical translation Hajos-Korcsok, Eva
2013
9 4S p. P300
artikel
623 Cross-talk between PI3K/Akt pathway and PP2A regulates tau site specific phosphorylation Yin, Xiaomin
2013
9 4S p. P713
artikel
624 CSF and PPA Cohen, Lora
2013
9 4S p. P372
artikel
625 CSF beta-amyloid 42 and t-tau profile in murine models of cerebral beta-amyloidosis Maia, Luis
2013
9 4S p. P831-P832
artikel
626 CSF beta-amyloid 1-42, but not CSF tau, phosphorylated tau or hippocampal atrophy on MRI relate to Alzheimer's disease pathology load in the brain Bouwman, Femke
2013
9 4S p. P433
artikel
627 CSF beta-amyloid 42, CSF tau, hippocampal volume and verbal episodic memory performance in early versus late mild cognitive impairment Wolfsgruber, Steffen
2013
9 4S p. P218
artikel
628 CSF biomarkers and APOE genotype as predictors of clinical progression in patients with subjective complaints Van der Flier, Wiesje
2013
9 4S p. P824
artikel
629 CSF biomarkers for Alzheimer's pathology and the effect size of APOE-ε4 Andreasson, Ulf
2013
9 4S p. P174
artikel
630 CSF biomarkers predict longitudinal decline in memory and executive functioning in patients with subjective complaints van Harten, Argonde
2013
9 4S p. P522
artikel
631 CSF biomarker variability in the Alzheimer's Association quality control program Andreasson, Ulf
2013
9 4S p. P213-P214
artikel
632 CSF PKR can predict cognitive decline in Alzheimer’s disease Hugon, Jacques
2013
9 4S p. P129
artikel
633 CSF SAPPβ, beta-amyloid 42, tau and p-tau levels in alzheimer's disease and dementia with Lewy bodies Kanemaru, Kazutomi
2013
9 4S p. P367
artikel
634 CSF sphingolipid levels correlate with CSF beta-amyloid and tau Mielke, Michelle
2013
9 4S p. P200-P201
artikel
635 CSF tau protein phosphorylated at threonine 231 as a potential biomarker of early-stage Alzheimer's disease Babic, Mirjana
2013
9 4S p. P717
artikel
636 Cultural aspects of end-of-life care issues in dementia: An exploratory study Kumar, Sudhir
2013
9 4S p. P494-P495
artikel
637 Curcumin analogues attenuate copper-induced crosslinking of beta-amyloid Ran, Chongzhao
2013
9 4S p. P503-P504
artikel
638 Curcumin-donepezil–loaded nanostructured lipid carriers for intranasal delivery in an Alzheimer's disease model Sood, Sumeet
2013
9 4S p. P299
artikel
639 Cytokines analysis in therapeutic and sub-therapeutic lithium-treated primary neuron and glia co-culture Kerr, Daniel
2013
9 4S p. P351
artikel
640 Deaf With Dementia Woll, Bencie
2013
9 4S p. P310
artikel
641 Decision quality and the use of cardiac rhythm regulating devices in adults with cognitive impairment Fowler, Nicole
2013
9 4S p. P634
artikel
642 Decline of fiber tract integrity over the adult age range: A diffusion spectrum imaging study Teipel, Stefan
2013
9 4S p. P92
artikel
643 Decline of fiber tract integrity over the adult age range: A diffusion spectrum imaging study Teipel, Stefan
2013
9 4S p. P259-P260
artikel
644 Decreased gray matter volume in postmenopausal women who report cognitive complaints Zurkovsky, Lilia
2013
9 4S p. P399
artikel
645 Decreased resting state functional connectivity at baseline predicts subjective memory complaints after 1 year in cognitively normal individuals and individuals with mild cognitive impairment Vannini, Patrizia
2013
9 4S p. P110
artikel
646 Decreased resting-state functional connectivity of posterior cingulate cortex in amnestic MCI-to-Alzheimer’s disease converters and non-converters Han, Ying
2013
9 4S p. P832-P833
artikel
647 Deep subcortical white-matter hyperintensities independently predict depression in people with mild cognitive impairment Kim, Doh Kwan
2013
9 4S p. P409
artikel
648 Deficits in semantic cuing, proactive and retroactive interference as early features of Alzheimer's disease Curiel, Rosie
2013
9 4S p. P456
artikel
649 Defining clinical boundaries between posterior cortical atrophy and early-onset Alzheimer's disease Suárez-González, Aida
2013
9 4S p. P741
artikel
650 Delaying early phases of cognitive decline associated with Alzheimer's disease: Challenges for international phase III therapeutic trials Brannan, Stephen
2013
9 4S p. P292-P293
artikel
651 Delay of Alzheimer's-like pathology in mice with 7,8-dihydroxyflavone Delgado-Morales, Raul
2013
9 4S p. P815
artikel
652 Delineating the relationship between cognitive measures and functional connectivity in Alzheimer's disease Devous, Michael
2013
9 4S p. P685
artikel
653 Delirium Modifies the Relationship Between Neuropathology and Cognitive Decline: Results in 987 Brain Autopsies from three Population-Based Studies Davis, Daniel
2013
9 4S p. P335-P336
artikel
654 Delirium superimposed on dementia: Some preliminary findings Kolanowski, Ann
2013
9 4S p. P310
artikel
655 Delivery of neuroprotective polyphenol to the brain via an intranasal route for management of Alzheimer's disease Sood, Sumeet
2013
9 4S p. P299
artikel
656 Dementia care in Haiti: Needs and opportunities for capacity building Pierre, Michel
2013
9 4S p. P482-P483
artikel
657 Dementia epidemiology in Korea: Comparison of the results from the Nationwide Survey on the Dementia Epidemiology (NaSDEK) 2008 and the NaSDEK 2012 Han, Jiwon
2013
9 4S p. P687
artikel
658 Dementia in Asia: Report of the Wave 2 Asia dementia expert survey Hee Suh, Guk
2013
9 4S p. P469
artikel
659 DEMNET-D: Evaluating dementia care networks in Germany Wolf-Ostermann, Karin
2013
9 4S p. P643
artikel
660 Description of the methods and analysis used to determine the direct and indirect costs of dementia: Preliminary results Ferretti, Ceres
2013
9 4S p. P465-P468
artikel
661 Designing the next generation of disease modification trials in people with early Alzheimer's disease: Learnings from recently completed programs in mild-to-moderate populations Romano, Steven
2013
9 4S p. P303-P304
artikel
662 Desmosterol: A new plasma biomarker for Alzheimer's disease Sato, Yoshiaki
2013
9 4S p. P236-P237
artikel
663 Detectable levels of white matter PHF-tau in Alzheimer's disease Hung, Lin
2013
9 4S p. P261
artikel
664 Detecting cognitive evidence of preclinical Alzheimer's disease Rentz, Dorene
2013
9 4S p. P6
artikel
665 Detecting progranulin mutations in people with atypical Alzheimer's disease Krudop, Welmoed
2013
9 4S p. P170
artikel
666 Detecting urinary AD7C-NTP level to diagnose Alzheimer's disease Wang, Rong
2013
9 4S p. P730
artikel
667 Detection and quantification of novel tau/phospho-tau epitopes in CSF using a multiplex assay approach De Vos, Ann
2013
9 4S p. P332
artikel
668 Detection of Alzheimer's disease–related biomarkers based upon metabolite profiling study Tsutsui, Haruhito
2013
9 4S p. P209
artikel
669 Detection of distinct neuropsychiatric symptom clusters at early- versus late-stages of Alzheimer's disease Rockwood, Kenneth
2013
9 4S p. P664-P665
artikel
670 Detection of mild cognitive impairment and early-stage dementia with an audio-recorded cognitive scale Sewell, Margaret
2013
9 4S p. P636
artikel
671 Detection of retinal nerve fibre layer defects in Alzheimer's dementia using SD-OCT Hausner, Lucrezia
2013
9 4S p. P196
artikel
672 Detection of soluble oligomeric tau with morphology-specific antibody fragments as a potential diagnostic method for Alzheimer's disease Tian, Huilai
2013
9 4S p. P230
artikel
673 Developing a clinic-based caregiver support program for early- and moderate-stage dementia Park, Myonghwa
2013
9 4S p. P484-P485
artikel
674 Developing an in vitro-in vivo model to study the impact of increasing brain APOE levels on cardiovascular safety Sylvain, Emily
2013
9 4S p. P814
artikel
675 Developing a person-centered medical home for people living with dementia Lawhorne, Larry
2013
9 4S p. P344
artikel
676 Developing Usp14 inhibitors as disease-modifying therapeutics for protein aggregation diseases Reinhart, Peter
2013
9 4S p. P512-P513
artikel
677 Development and characterization of a validated multiplex panel for detection of beta-amyloid peptides in human CSF Hapip, Sara
2013
9 4S p. P243
artikel
678 Development and implementation of the National Alzheimer's Prevention Registry Langbaum, Jessica
2013
9 4S p. P280
artikel
679 Development and validation of a brief dementia risk assessment tool for use in primary care Barnes, Deborah
2013
9 4S p. P116
artikel
680 Development and validation of a brief dementia risk assessment tool for use in primary care Beiser, Alexa
2013
9 4S p. P731-P732
artikel
681 Development and validation of a new performance-based measurement of IADL for Chinese-speaking elders Chen, Cheng-Sheng
2013
9 4S p. P742-P743
artikel
682 Development and validation of a screening algorithm for Alzheimer's disease using the categorical fluency test Chi, Yeon Kyung
2013
9 4S p. P459-P460
artikel
683 Development of a highly sensitive and selective liquid chromatography tandem mass spectrometric method for the evaluation of beta-amyloid biomarkers in the olfactory bulb and nasal mucosa Mochizuki, Nana
2013
9 4S p. P209
artikel
684 Development of a new PET biomarker for synaptic function Salmon, Eric
2013
9 4S p. P413-P414
artikel
685 Development of an experimental model of insulin resistance–induced Alzheimer's disease Sachdeva, Anand
2013
9 4S p. P156-P157
artikel
686 Development of a sporadic animal model of Alzheimer's disease Sharp, Frank
2013
9 4S p. P160
artikel
687 Development of a targeted mass spectrometry method for accurate quantification of human sirtuins in biological samples Jayasena, Tharusha
2013
9 4S p. P357
artikel
688 Development of dementia in a cohort of elderly who frequently use ambulatory health services Seinhart, Daniel
2013
9 4S p. P764-P765
artikel
689 Development of novel assay panels for the detection of Alzheimer's and Parksinson's disease biomarkers in human matrices Puskar, Nyssa
2013
9 4S p. P228
artikel
690 Development of the Dimensions of Living with Memory Loss interview McGee, Jocelyn
2013
9 4S p. P644-P645
artikel
691 Development of white matter lesions is preceded by changes in normal-appearing white matter de Groot, Marius
2013
9 4S p. P619-P620
artikel
692 Development of white matter lesions is preceded by changes in normal-appearing white matter de Groot, Marius
2013
9 4S p. P7
artikel
693 Deviations from a model of estimated spatiotemporal patterns of amyloid deposition in healthy aging are predictive of cognitive decline Yotter, Rachel
2013
9 4S p. P14-P15
artikel
694 Deviations from a model of estimated spatiotemporal patterns of amyloid deposition in healthy aging is predictive of cognitive decline Yotter, Rachel
2013
9 4S p. P695-P696
artikel
695 Diagnosis of cognitive disorders in Latin America: New technologies or more knowledge is needed O' Neill, Santiago
2013
9 4S p. P645
artikel
696 Diagnosis of dementia: What are the attitudes of relatives in Argentina? Bustin, Julian
2013
9 4S p. P471
artikel
697 Diagnosis of "the other dementias": Not uncommon or necessarily isolated Dickerson, Bradford
2013
9 4S p. P1
artikel
698 Diagnostic impact of CSF biomarkers for Alzheimer's disease in a memory clinic setting Duits, Flora
2013
9 4S p. P144-P145
artikel
699 Diagnostic testing and medication utilization in Alzheimer's disease in a large de-identified database Lerner, Alan
2013
9 4S p. P465
artikel
700 Diet and cognition: Baseline associations in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) Lehtisalo, Jenni
2013
9 4S p. P604-P605
artikel
701 Dietary minerals and risk of MCI Cherbuin, Nicolas
2013
9 4S p. P612-P613
artikel
702 Dietary n-3 fatty acids inversely associated with higher levels of presynaptic protein in human brain Tangney, Christy
2013
9 4S p. P605-P606
artikel
703 Diet-induced obesity and low testosterone interact to increase neuroinflammation and reduce neuron survival Jayaraman, Anusha
2013
9 4S p. P353
artikel
704 Differences in biomarker profiles of people with amnestic and nonamnestic mild cognitive impairment Porto, Fábio
2013
9 4S p. P253-P254
artikel
705 Differential anatomical correlates of objective and subjective memory in older individuals across a spectrum of memory impairment Wigman, Sarah
2013
9 4S p. P49
artikel
706 Differential effect of depression on cognitive and daily function in people with MCI and Alzheimer's dementia Lee, Kyoung-Uk
2013
9 4S p. P765-P766
artikel
707 Differential expression of tumor necrosis factor (TNF) α between the temporal and cerebellar cortices of people with Alzheimer's disease compared with alterations in TNF receptor expression Konishi, Yoshihiro
2013
9 4S p. P568
artikel
708 Differential impact of amyloidosis and tau pathology on brain metabolism Cheewakriengkrai, Laksanun
2013
9 4S p. P580-P581
artikel
709 Differential impact of amyloidosis and tau pathology on brain metabolism Cheewakriengkrai, Laksanun
2013
9 4S p. P17
artikel
710 Differential impact of high and low molecular mass beta-amyloid oligomers on synapse density, receptor composition and memory in mice Ferreira, Sergio
2013
9 4S p. P520
artikel
711 Differential item functioning and the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) among people with Alzheimer's disease Khan, Anzalee
2013
9 4S p. P460-P461
artikel
712 Differential tau neuropathology within the nucleus of N. oculomotorius in Alzheimer's disease Scinto, Leonard
2013
9 4S p. P439
artikel
713 Different patterns of functional connectivity changes in APOE-ε4 carriers from early to mid-adulthood Rusted, Jennifer
2013
9 4S p. P256
artikel
714 Diffusion tensor imaging (DTI) of white matter integrity, but not structural or perfusion MRI, identifies changes in preclinical Alzheimer's disease Chao, Linda
2013
9 4S p. P870-P871
artikel
715 Diffusion tensor imaging in primary progresive aphasia Amengual, Alejandra
2013
9 4S p. P577-P578
artikel
716 Diffusion tensor imaging of the corpus callosum in frontotemporal dementia: A study in the Indian population Gupta, Rohit
2013
9 4S p. P260
artikel
717 Diffusion-tensor magnetic resonance imaging as a biomarker of structural damage in mild cognitive impairment and Alzheimer's disease dementia Demey, Ignacio
2013
9 4S p. P402
artikel
718 Direct and indirect assessment of functional performance in behavioral variant frontotemporal dementia (bvFTD) Yassuda, Mônica
2013
9 4S p. P749-P750
artikel
719 Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia: Involvement of NMDA receptor activation Mogi, Masaki
2013
9 4S p. P721-P722
artikel
720 Disclosing amyloid imaging results in MCI: What do patients and families want, and why? Lingler, Jennifer
2013
9 4S p. P533-P534
artikel
721 Disconnect between brain and CSF drug exposure and beta-amyloid levels following BACE inhibition Gonzales, Cathleen
2013
9 4S p. P497-P498
artikel
722 Discovery of Alzheimer's disease biomarkers associated with inflammation using a novel validated cytokine screening panel Oberoi, Pankaj
2013
9 4S p. P244
artikel
723 Discovery of novel subtype-selective M1-positive allosteric modulators Stauffer, Shaun
2013
9 4S p. P840
artikel
724 Discussant Sperling, Reisa A.
2013
9 4S p. P826
artikel
725 Disease progression markers from connected speech Ahmed, Samrah
2013
9 4S p. P453
artikel
726 Disease progression modeling of bapineuzumab utilizing Alzheimer's Disability Assessment for Dementia scores Samtani, Mahesh
2013
9 4S p. P284
artikel
727 Disorientation in amnestic mild cognitive impairment is correlated with hypometabolism in the posterior cingulate Moon, So
2013
9 4S p. P446
artikel
728 Disrupted functional connectivity in autosomal dominant Alzheimer’s disease demonstrates network specificity and precedes brain volume loss: Findings from DIAN Chhatwal, Jasmeer
2013
9 4S p. P49-P50
artikel
729 Disrupted functional connectivity in autosomal dominant Alzheimer’s disease demonstrates network specificity and precedes brain volume loss: Findings from the Dominantly Inherited Alzheimer Network Chhatwal, Jasmeer
2013
9 4S p. P684-P685
artikel
730 Dissecting the function of the amyloid precursor protein Liu, Helio
2013
9 4S p. P186
artikel
731 Dissociating volume and intensity differences in familial Alzheimer's disease Cash, David
2013
9 4S p. P603
artikel
732 Dissociating volume and intensity differences in familial Alzheimer's disease Cash, David
2013
9 4S p. P46-P47
artikel
733 Dissociations between entorhinal and hippocampal activity in cognitively normal older adults with and without beta-amyloid deposition Huijbers, Willem
2013
9 4S p. P17
artikel
734 Distinct anatomical subtypes of Alzheimer's disease Noh, Young
2013
9 4S p. P379-P380
artikel
735 Distinct functions of BACE1 and BACE2 in neuregulin processing and melanocyte migration Haass, Christian
2013
9 4S p. P144
artikel
736 Distribution analysis of CMB in people with cognitive impairment and stroke Park, Hyun Jeung
2013
9 4S p. P390
artikel
737 Distribution of amyloid burden in PiB(+) subcortical vascular cognitive impairment compared with Alzheimer's disease Noh, Young
2013
9 4S p. P380
artikel
738 Disturbances of innate immunity in Alzheimer's disease: Possible therapeutic approach Leszek, Jerzy
2013
9 4S p. P350-P351
artikel
739 3D mapping of delayed recall of the Rey Auditory Verbal Learning Test in clinical and preclinical Alzheimer's disease Eastman, Jennifer
2013
9 4S p. P77-P78
artikel
740 DNA beta-amyloid 42 vaccination as a possible immunotherapy for Alzheimer's disease: The development of a beta-amyloid 1-42 antibody-producing pool of plasma cells in the bone marrow of immunized mice Lambracht-Washington, Doris
2013
9 4S p. P501-P502
artikel
741 DNA damage in peripheral blood cells is associated with Alzheimer's disease (AD)-related plasma proteins in individuals at risk for progression to AD Risacher, Shannon
2013
9 4S p. P64
artikel
742 DNA damage in peripheral blood cells is associated with Alzheimer's-related plasma proteins in individuals at risk for progression to Alzheimer's disease Risacher, Shannon
2013
9 4S p. P171
artikel
743 Do astrocytes supplement axonal transport as a local supply and maintenance source for synapses? Implications for Alzheimer's disease Engel, Peter
2013
9 4S p. P573-P574
artikel
744 Does an interdisciplinary network improve dementia care? Results from the IDemUck-study Thyrian, Jochen René
2013
9 4S p. P527
artikel
745 Does APOE-ε4 confer risk for Alzheimer's disease through regionally distributed white matter hyperintensities? Brickman, Adam
2013
9 4S p. P254
artikel
746 Does therapy for an overactive bladder have an effect on cognitive function? Esin, Ece
2013
9 4S p. P737
artikel
747 Dog-assisted therapy for people with dementia: A randomized, controlled trial Holthoff, Vjera
2013
9 4S p. P297
artikel
748 Do "healthy" women live too long? Kuller, Lewis
2013
9 4S p. P672
artikel
749 Do microbleeds predict stroke in Alzheimer's disease (MISTRAL)? Study design and first results Benedictus, Marije
2013
9 4S p. P590
artikel
750 Do microbleeds predict stroke in Alzheimer's disease (MISTRAL)? Study design and first results Benedictus, Marije
2013
9 4S p. P50
artikel
751 Donepezil can prolong lifespan in Alzheimer's disease: The Tajiri Project 1999-2012 Meguro, Kenichi
2013
9 4S p. P740
artikel
752 Donepezil prevented the cognitive impairment induced by sleep deprivation in a nonhuman primate, the grey mouse lemur Rahman, Anisur
2013
9 4S p. P155
artikel
753 Donepezil reduces phosphorylation levels of tau protein in a cellular model of tauopathy Hamano, Tadanori
2013
9 4S p. P305
artikel
754 Dosage-dependent accumulation of beta-amyloid 42 in SHSY5Y cells by insulin treatment and its implications in Alzheimer's disease pathogenesis Basu, Gargi Chatterjee
2013
9 4S p. P184
artikel
755 Do socioeconomic disparities explain higher dementia incidence among black older adults? Yaffe, Kristine
2013
9 4S p. P343-P344
artikel
756 Do statin drugs impair cognition? A systematic review and meta-analysis Ott, Brian
2013
9 4S p. P666
artikel
757 Dramatic improvement with donepezil in a case of dementia with Lewy bodies Allen, Laura
2013
9 4S p. P735
artikel
758 Driving issues in people with frontotemporal dementia Dugan, Elizabeth
2013
9 4S p. P642-P643
artikel
759 Dropout and its effect on the AIBL study Graham, Petra
2013
9 4S p. P205
artikel
760 DSP-8658, a novel selective PPARα/γ modulator with good safety profiles, exhibits significant procognitive effects in rodents Ishikawa, Taizo
2013
9 4S p. P892-P893
artikel
761 Dual-pathway carboxypeptidase activity is an intrinsic property of gamma-secretase Fernandez, Marty
2013
9 4S p. P142-P143
artikel
762 Dual specificity tyrosine-phosphorylation-regulated kinase 1A upregulates tau expression Qian, Wei
2013
9 4S p. P718
artikel
763 Dual-task gait performance in mild cognitive impairment may predict Alzheimer's disease conversion Chong, Mei Sian
2013
9 4S p. P764
artikel
764 Dynamic optical imaging of a cleavable CPP-bound, dual-NIR fluorescent/MRI probe targeting cathepsin D Snir, Jonatan
2013
9 4S p. P99
artikel
765 Dynamic optical imaging of a cleavable CPP-bound dual NIR fluorescent/MRI probe targeting cathepsin D Snir, Jonatan
2013
9 4S p. P226
artikel
766 Dynamic processes in life-course: exposure to risk and incidence of dementia—CFAS-II Matthews, Fiona
2013
9 4S p. P511
artikel
767 Early detection: Assessing the landscape of vulnerability Pierce, Robin
2013
9 4S p. P643-P644
artikel
768 Early detection of Alzheimer's disease by analysis of brain-enriched miRNA biomarkers in plasma Sheinerman, Kira
2013
9 4S p. P236
artikel
769 Early detection of Alzheimer's disease: Probing mitochondrial function in the periphery Lakatos, Anita
2013
9 4S p. P349
artikel
770 Early detection of mild cognitive impairment: Would it be cost-effective? Barnett, Jennifer
2013
9 4S p. P638
artikel
771 Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between FDG-PET and IMP-SPECT Chiba, Yuhei
2013
9 4S p. P386
artikel
772 Early differential diagnostic between Alzheimer's disease and dementia with Lewy bodies: Comparison between FDG-PET and IMP-SPECT Chiba, Yuhei
2013
9 4S p. P374-P375
artikel
773 Early pathological changes due to Alzheimer's disease are detected by graph theoretical measures of functional connectivity Brier, Matthew
2013
9 4S p. P419
artikel
774 Early pathological changes due to Alzheimer's disease are detected by graph theoretical measures of functional connectivity Brier, Matthew
2013
9 4S p. P50
artikel
775 Early psychosocial intervention did not delay institutionalization in patients with Alzheimer’s disease: ALSOVA study reports Koivisto, Anne
2013
9 4S p. P527
artikel
776 Early-to mid-life formal training in music is associated with improved late-life semantic and episodic memory among cognitively normal older adults Abner, Erin
2013
9 4S p. P793
artikel
777 Editorial Board 2013
9 4S p. A6
artikel
778 E64d treatment improves outcomes in animal models of traumatic brain injury, ischemia and Alzheimer's disease through inhibiting cathepsin B Hook, Greg
2013
9 4S p. P703
artikel
779 EEG markers of motor activity in lemurs Infarinato, Francesco
2013
9 4S p. P166-P167
artikel
780 EEG markers of motor activity in mice in physiological and pathological aging Del Percio, Claudio
2013
9 4S p. P166
artikel
781 EEG markers of motor activity in wild type mice Del Percio, Claudio
2013
9 4S p. P165-P166
artikel
782 EEG phenotyping and sub-phenotyping of Alzheimer's disease and other dementias Jóhannesson, Gísli
2013
9 4S p. P332-P333
artikel
783 Effectiveness of a cognitive-behavioral group intervention for Latino families in management of Alzheimer's disease neuropsychiatric symptoms Gonyea, Judith
2013
9 4S p. P884
artikel
784 Effectiveness of a fotonovela (FN) to Latino dementia caregivers on reducing caregiving-related self-reported stress and depression Tzuang, Marian
2013
9 4S p. P325
artikel
785 Effectiveness of an internet intervention for family caregivers of people with dementia Blom, Marco
2013
9 4S p. P882
artikel
786 Effectiveness of Community-dwelling Group Validation Therapy (CGVT) for dementia patients in Korea Lee, Dong Young
2013
9 4S p. P888
artikel
787 Effectiveness of the Montreal Cognitive Assessment (MoCA) for assessing frontal hypoperfusion in people with vascular dementia: The Osaki-Tajiri Project Akanuma, Kyoko
2013
9 4S p. P637
artikel
788 Effect of Alzheimer's risk variant CLU on EEG alterations in normal aging Ponomareva, Natalya
2013
9 4S p. P221-P222
artikel
789 Effect of a novel beta-amyloid peptide vaccine on brain beta-amyloid deposition in Tg2576 mice Makino, Mitsuhiro
2013
9 4S p. P502-P503
artikel
790 Effect of a phantom-based distortion correction of MRI for assessment of Alzheimer's disease using a tensor-based morphmetry approach Maikusa, Norihide
2013
9 4S p. P423
artikel
791 Effect of APOE and family history of dementia on Alzheimer's disease imaging biomarkers in cognitively normal subjects Vemuri, Prashanthi
2013
9 4S p. P257
artikel
792 Effect of APOE and family history of dementia on Alzheimer’s imaging biomarkers in cognitively normal individuals Vemuri, Prashanthi
2013
9 4S p. P80
artikel
793 Effect of APOE-ε4 carrier status on donepezil response in people with mild-to-moderate Alzheimer's dementia Waring, Jeffrey
2013
9 4S p. P293
artikel
794 Effect of APOE genotype on clinical trial outcomes Schneider, Lon
2013
9 4S p. P290
artikel
795 Effect of apolipoprotein E-ε4 status on brain atrophy in 1-year repeat MRI data from cognitively normal elderly individuals Matsuda, Hiroshi
2013
9 4S p. P391-P392
artikel
796 Effect of A673T mutation on APP processing by BACE1 and its significance for Alzheimer's disease therapeutic research Ambroise, Claude
2013
9 4S p. P809-P810
artikel
797 Effect of bapineuzumab on CSF p-tau and t-tau in mild-to-moderate Alzheimer's disease: Results from two phase III trials in APOE-ε4 carriers and noncarriers Streffer, Johannes
2013
9 4S p. P138
artikel
798 Effect of body mass index on the efficacy, safety and tolerability of a higher-dose 13.3 mg/24 h rivastigmine patch in people with severe Alzheimer's disease Sadowsky, Carl
2013
9 4S p. P654
artikel
799 Effect of chronic treatment with lithium on protein cyclin-dependent kinase 5 (CDK5) and tau protein in a primary culture of cortical neurons Carvalho, Marília
2013
9 4S p. P718
artikel
800 Effect of clusterin knockdown in an Alzheimer's disease mouse model Basehore, Heather
2013
9 4S p. P356-P357
artikel
801 Effect of cognitively and physically stimulating activities on PiB-PET Cohen, Ann
2013
9 4S p. P394
artikel
802 Effect of cognitively and physically stimulating activities on PiB-PET Cohen, Ann
2013
9 4S p. P25
artikel
803 Effect of combination of 5HT6 and nonselective and selective 5HT2a antagonist in a model of cognitive impairment Nirogi, Ramakrishna
2013
9 4S p. P816-P817
artikel
804 Effect of disease severity on cognitive decline among people using Cerefolin® Shankle, William
2013
9 4S p. P802
artikel
805 Effect of duration of Cerefolin® use on cognitive decline in Alzheimer's or cerebrovascular disease Hara, Junko
2013
9 4S p. P802
artikel
806 Effect of granulocyte colony stimulating factor (GCSF) alone and in combination with acetylcholinesterase inhibitor improves memory in a beta-amyloid–induced experimental model of Alzheimer's disease Medhi, Bikash
2013
9 4S p. P157
artikel
807 Effect of homocysteine on hippocampal atrophy independent of cerebral amyloid deposition and vascular burden in normal aging, MCI and Alzheimer’s disease Choe, Young Min
2013
9 4S p. P18
artikel
808 Effect of homocysteine on hippocampal atrophy independent of cerebral amyloid deposition and vascular burden in normal aging, mild cognitive impairment, and Alzheimer’s disease Choe, Young Min
2013
9 4S p. P699
artikel
809 Effect of hyperinsulinemia on cortical thinning Yoon, Cindy
2013
9 4S p. P618
artikel
810 Effect of hypertension on the resting-state functional connectivity in patients with Alzheimer's disease Son, Sang Joon
2013
9 4S p. P875-P876
artikel
811 Effect of intellectual lifestyle and Alzheimer's disease biomarkers on rate of cognitive decline: Mayo Clinic Study of Aging Vemuri, Prashanthi
2013
9 4S p. P635
artikel
812 Effect of IVIg in preserving human primary neurons and protecting them against oxidative stress Lahiri, Debomoy
2013
9 4S p. P800
artikel
813 Effect of measurement variability on hippocampal volume–based clinical trial enrichment Yu, Peng
2013
9 4S p. P587
artikel
814 Effect of measurement variability on hippocampal volume-based clinical trial enrichment Yu, Peng
2013
9 4S p. P26
artikel
815 Effect of memantine on the progression of driving impairment in mild Alzheimer's disease Holland, Peter
2013
9 4S p. P886-P887
artikel
816 Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment Kennedy, Richard
2013
9 4S p. P691
artikel
817 Effect of tau on the transport of ChAT in HEK293/tau cell by fluorescence recovery after photobleaching technology Cao, Jie
2013
9 4S p. P717
artikel
818 Effect of treadmill running on soluble beta-amyloid concentrations in brains of young Tg2576 mice Jones, Maria
2013
9 4S p. P709
artikel
819 Effect of vitamin B12 deficiency treatment on cognitive function in Alzheimer's disease Karadas, Omer
2013
9 4S p. P302
artikel
820 Effect of vitamin B12 treatment on event-related endogen potentials in Alzheimer's disease Gul, Hakan
2013
9 4S p. P302
artikel
821 Effects of age and apolipoprotein E genotype on memory function: An fMRI study Matura, Silke
2013
9 4S p. P252
artikel
822 Effects of aliquot size, Tween-20 and tube type on beta-amyloid 42, tau and p-tau(181) measurements Schauer, Stephen
2013
9 4S p. P213
artikel
823 Effects of APOE-ε4 and APOE-ε2 alleles on hippocampal volumes in 1,412 healthy young adolescents: The IMAGEN study Khan, Wasim
2013
9 4S p. P872-P874
artikel
824 Effects of APOE-ε4 on lacunar infarcts, white matter lesions and brain amyloid: A study among people with subcortical vascular cognitive impairment Ye, Byoung Seok
2013
9 4S p. P369-P370
artikel
825 Effects of APOE-ε4 on regional cerebral amyloid deposition and gray matter atrophy in mild cognitive impairment with PiB-PET-confirmed amyloid pathology: Results from J-ADNI Ishii, Kazunari
2013
9 4S p. P405
artikel
826 Effects of beta-amyloid deposition and APOE-ε4 on episodic memory: A lifespan approach Bischof, Gerard
2013
9 4S p. P397
artikel
827 Effects of biomarkers on cognitive domains in Alzheimer's disease Yavorsky, Christian
2013
9 4S p. P474
artikel
828 Effects of changing from non-accelerated to accelerated MRI in brain atrophy measurement Leung, Kelvin
2013
9 4S p. P593-P594
artikel
829 Effects of changing from nonaccelerated to accelerated MRI in brain atrophy measurement Leung, Kelvin
2013
9 4S p. P90
artikel
830 Effects of cholinesterase inhibitors on gait and balance in elderly people with Alzheimer's disease Isik, Ahmet Turan
2013
9 4S p. P654
artikel
831 Effects of cognitive training and rTMS in Alzheimer's disease Brem, Anna-Katharine
2013
9 4S p. P664
artikel
832 Effects of cognitive training, as measured with fMRI, in mild cognitive impairment: A brief review Simon, Sharon Sanz
2013
9 4S p. P298
artikel
833 Effects of depression and mild cognitive impairment on the hippocampal functional connectivity network in the elderly Goveas, Joseph
2013
9 4S p. P112-P113
artikel
834 Effects of depression and mild cognitive impairment on the hippocampal functional connectivity network in the elderly Goveas, Joseph
2013
9 4S p. P416-P417
artikel
835 Effects of early Alzheimer's disease (AD) on structure and functional connectivity of the hippocampus in cognitively normal elderly Song, Zhuang
2013
9 4S p. P230-P231
artikel
836 Effects of MS4A variants on cerebrospinal fluid beta-amyloid 1-42 Elias-Sonnenschein, Lyzel
2013
9 4S p. P229-P230
artikel
837 Effects of role-training for family caregivers of people with dementia Shigemori, Kenta
2013
9 4S p. P815-P816
artikel
838 Effects of solanezumab versus placebo administration on biomarkers in people with mild-to-moderate Alzheimer's disease: Results from two phase III clinical trials Dean, Robert
2013
9 4S p. P283
artikel
839 Effects of space radiation on hippocampal-dependent learning and neuropathology in wild-type and Alzheimer's disease transgenic mice Moncaster, Juliet
2013
9 4S p. P190
artikel
840 Effects of the SORL1 Alzheimer's disease risk gene across the human lifespan Felsky, Daniel
2013
9 4S p. P678
artikel
841 Effects of treatment with memantine on two Patients diagnosed with preclinical dementia with Lewy bodies Takaya, Masahiko
2013
9 4S p. P301
artikel
842 Effects of various antidementia drugs for Alzheimer`s disease as examined by SPECT imaging using SPM8 Kanaya, Kiyoshi
2013
9 4S p. P301
artikel
843 Effects of white matter integrity on late-life depression in the Framingham Heart Study Qiu, Wendy
2013
9 4S p. P627
artikel
844 Efficacy and safety of FFDS tablets in people with mild-to-moderate vascular dementia: A 24-week randomized, double-blind, placebo, parallel-controlled trial Tian, Jinzhou
2013
9 4S p. P670-P671
artikel
845 Efficacy and safety of memantine in people with moderate-to-severe Alzheimer's disease: Results of a pooled analysis of randomized, double-blind placebo-controlled trials in Japan Nakamura, Yu
2013
9 4S p. P297
artikel
846 Efficacy and safety of the alpha7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia Gault, Laura
2013
9 4S p. P138
artikel
847 Efficacy and usability of a brain-computer interface system in improving cognition in the elderly Lee, Tih-Shih
2013
9 4S p. P296
artikel
848 Efficacy of an outpatient cognitive rehabilitation program in people with acquired brain damage in connection with the time elapsed before treatment initiation Rojas, Galeno
2013
9 4S p. P799-P800
artikel
849 Efficacy of a therapeutic cognitive training program for memory and neuropsychological deficits in a dementia population Fisher, Barbara
2013
9 4S p. P294
artikel
850 Efficacy of donepezil hydrochloride treatment for Alzheimer's disease depending on apolipoprotein E polymorphism in Ukrainians Bachinskaya, Natalia
2013
9 4S p. P663
artikel
851 Efficacy of memantine in people with moderate to severe Alzheimer's disease with and without background donepezil therapy: Pooled analysis of four randomized trials Graham, Stephen
2013
9 4S p. P656
artikel
852 Efficacy of multimodal intervention for people with Alzheimer's disease Schiffczyk, Claudia
2013
9 4S p. P654
artikel
853 Efficacy of musical interventions in moderate to severe dementia: Evidence from a randomized controlled trial Narme, Pauline
2013
9 4S p. P117
artikel
854 Efficacy of solanezumab in patients with mild or moderate Alzheimer's disease: Pooled analyses findings from two phase III studies Carlson, Christopher
2013
9 4S p. P139
artikel
855 Efficacy, safety and tolerability of a higher-dose 13.3 mg/24 h rivastigmine patch in people with severe Alzheimer's disease with and without concomitant memantine use Grossberg, George
2013
9 4S p. P656
artikel
856 Egb761 reduces zinc-induced tau phosphorylation at Ser262 in rat primary cortical neurons Kwon, Kyoung Ja
2013
9 4S p. P716
artikel
857 Electrochemical assay for monitoring tau/antibodies interactions Martic, Sanela
2013
9 4S p. P212
artikel
858 Elevated baseline PiB-PET amyloid load in asymptomatic controls predicts increased hippocampal and whole brain atrophy over the following 3 years Andrews, Katharine
2013
9 4S p. P316
artikel
859 Elucidating Alzheimer’s disease neuronal death by the ‘calpain-cathepsin hypothesis' Yamashima, Tetsumori
2013
9 4S p. P331
artikel
860 Elucidating the relationship between β2 adrenergic receptor, tau and mTOR Wisely, Elena
2013
9 4S p. P169
artikel
861 Elucidating the role of PZP in Alzheimer's disease Nijholt, Diana
2013
9 4S p. P363-P364
artikel
862 Emotional recognition of unrecognized visual stimuli in a person with posterior cortical atrophy Gonzalez-Gadea, María Luz
2013
9 4S p. P737-P738
artikel
863 End-of-life care implications of having a parent or sibling with Alzheimer's disease Ha, Jung-Hwa
2013
9 4S p. P325
artikel
864 Enhanced motor performance and motor learning in 3xTg-AD mice in two tests: A longitudinal study Stover, Kurt
2013
9 4S p. P497
artikel
865 Enhanced neuronal membrane and synapse formation by nutritional membrane precursors and cofactors van Wijk, Nick
2013
9 4S p. P801-P802
artikel
866 Enhancing brain cAMP trough PDE-7 inhibitors: A new Alzheimer’s disease pharmacotherapy approach Martinez, Ana
2013
9 4S p. P839-P840
artikel
867 Enhancing senior nursing students’ education of Alzheimer's disease: A partnership with the Alzheimer's Association Moore, Janet
2013
9 4S p. P481-P482
artikel
868 Entorhinal cortical thickness as a biomarker for preclinical Alzheimer's disease Yassa, Michael
2013
9 4S p. P863
artikel
869 Entorhinal thickness mediates the relationship between hippocampus volume and default-mode network connectivity independently of amyloid burden in cognitively intact elderly Ward, Andrew
2013
9 4S p. P106-P107
artikel
870 Environmental enrichment exerts a stronger impact on cognitive performance than does social interaction or nutritional supplementation Shea, Thomas
2013
9 4S p. P606-P607
artikel
871 Epidemiology of mild cognitive impairment: The Mayo Clinic Study of Aging Roberts, Rosebud
2013
9 4S p. P122
artikel
872 Epigenetic modifications reveal an effective use of the protein quality control system to suppress accumulation and toxicity of beta-amyloid 42 in the secretory pathway in neurons Iijima, Koichi
2013
9 4S p. P126
artikel
873 Epigenetic molecules are unable to translocate to the cell nucleus in Alzheimer's disease Mastroeni, Diego
2013
9 4S p. P572-P573
artikel
874 Epigenetic signature of the human APOE gene: Implications in Alzheimer's disease Yu, Chang-En
2013
9 4S p. P828-P829
artikel
875 Episodic memory performance and hippocampal volumes among people seeking care at a memory clinic Banks, Sarah
2013
9 4S p. P772
artikel
876 Episodic memory performance is associated with neuropathology in primary progressive aphasia Kielb, Stephanie
2013
9 4S p. P436
artikel
877 Episodic memory tests for screening Alzheimer's disease in illiterate and low-educated individuals: Comparison of rural and urban populations Maillet, Didier
2013
9 4S p. P784
artikel
878 Escalation of resistiveness-to-care behaviors in people with dementia during hygienic care Belzil, Guylaine
2013
9 4S p. P494
artikel
879 Establishing a blood test for Alzheimer's disease Zhu, Haihao
2013
9 4S p. P196
artikel
880 Establishing an Alzheimer's disease biomarker based on beta-amyloid analysis using postmortem samples, olfactory bulb and nasal mucosa with scrapings Akatsu, Hiroyasu
2013
9 4S p. P208-P209
artikel
881 Establishing apolipoprotein J as a potential candidate for Alzheimer's disease biomarker panel: Australian Imaging, Biomarker and Lifestyle (AIBL) flagship study of aging Gupta, Veer Bala
2013
9 4S p. P128
artikel
882 Establishment of a database on aging and dementia in the Philippines Dominguez, Jacqueline
2013
9 4S p. P741
artikel
883 Estimated quality adjusted life-years (QALY) associated with the degree of activities of daily living (ADL) of people with Alzheimer's disease Kasai, Mari
2013
9 4S p. P471
artikel
884 Estimating the risk of mild cognitive impairment and conversion to Alzheimer's disease Inzelberg, Rivka
2013
9 4S p. P612
artikel
885 Estrogen receptor-β regulation of insulin signaling and energy metabolism in APOE- ε2, ε3, ε4 brains Mao, Zisu
2013
9 4S p. P350
artikel
886 Ethnicity-specific pathways between biomarkers and cognition Royall, Donald
2013
9 4S p. P245
artikel
887 Evaluating TNF-alpha as a possible link in Alzheimer's disease and rheumatoid arthritis Paouri, Evangelia
2013
9 4S p. P161
artikel
888 Evaluation of amyloid-based enrichment using established and novel clinical instruments Yu, Peng
2013
9 4S p. P25-P26
artikel
889 Evaluation of amyloid-based enrichment using established and novel clinical instruments Yu, Peng
2013
9 4S p. P412-P413
artikel
890 Evaluation of a radiolabelled butyrylcholinesterase ligand, N-methyl-4-piperdinyl-4-[18F]-fluorobenzoate, in human brain tissues Jollymore, Courtney
2013
9 4S p. P385
artikel
891 Evaluation of a radiolabelled butyrylcholinesterase ligand, N-methyl-4-piperdinyl-4-[18F]-fluorobenzoate, in human brain tissues Jollymore, Courtney
2013
9 4S p. P42
artikel
892 Evaluation of beta-amyloid-lowering efficacy of a novel BACE1 inhibitor in multiple species Nolan, Charles
2013
9 4S p. P806
artikel
893 Evaluation of cerebral perfusion changes through SPECT in people with mild Alzheimer's disease after a cognitive rehabilitation program de Paula, Edneia
2013
9 4S p. P73
artikel
894 Evaluation of common changes in the aging brain: Comparing high- and low-field MRI Song, Xiaowei
2013
9 4S p. P109-P110
artikel
895 Evaluation of common changes in the aging brain: Comparing high- and low-field MRI Song, Xiaowei
2013
9 4S p. P399
artikel
896 Evaluation of pre-analytical and analytical factors that contribute to variability in CSF biomarker levels Shah, Aarti
2013
9 4S p. P211
artikel
897 Evaluation of the inverse U-shaped activation hypothesis in Alzheimer's disease and mild cognitive impairment: A quantitative meta-analysis of functional imaging research Terry, Douglas
2013
9 4S p. P51
artikel
898 Evaluation of the neuroprotective effect of salvigenin between the hippocampus and cortex of beta-amyloid–injected rats Esfandabadi, Ahmad Omidpanah
2013
9 4S p. P308
artikel
899 Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials Margolin, Richard
2013
9 4S p. P18
artikel
900 Evaluation of the relationship between TTP488 plasma concentrations and changes in ADAS-cog relative to placebo Burstein, Aaron
2013
9 4S p. P279-P280
artikel
901 Event-related beta responses of healthy individuals and individuals with mild cognitive impairment during a visual oddball paradigm Guntekin, Bahar
2013
9 4S p. P228-P229
artikel
902 Evidence-based provider tools for efficient identification and management of cognitive impairment Barclay, Terry
2013
9 4S p. P117
artikel
903 Evidence-based provider tools for efficient identification and management of cognitive impairment Barclay, Terry
2013
9 4S p. P754
artikel
904 Evidence for intact CNS antioxidant defenses in cognitively intact individuals who are amyloid-positive Mueller, Susanne
2013
9 4S p. P51
artikel
905 Evidence for intact CNS antioxidant defenses in cognitively intact people who are amyloid-positive Mueller, Susanne
2013
9 4S p. P390
artikel
906 Evidence of cross-cultural effects on the assessment of autobiographical memory in aging: Implications for cognitive assessment of dementia Venneri, Annalena
2013
9 4S p. P639
artikel
907 Evidence of learning or placebo effects relevant to clinical trials of mild cognitive impairment Edland, Steven
2013
9 4S p. P676
artikel
908 Evidence of massive neural plasticity induced by exercise in MCI patients Smith, J. Carson
2013
9 4S p. P250-P251
artikel
909 Evidence of microvascular network alterations in the retinas of people with Alzheimer's disease Cheung, Carol
2013
9 4S p. P743
artikel
910 Evidence of recessive Alzheimer's disease loci in Caribbean Hispanics: Genome-wide survey of runs of homozygosity Kakhki, Mahdi Ghani
2013
9 4S p. P174-P175
artikel
911 Evolution of hippocampal atrophy and episodic memory impairment along the Alzheimer disease biological continuum through the AD-CSF-Index Gispert, Juan
2013
9 4S p. P871
artikel
912 EVP-6124, an alpha7 nicotinic acetycholine receptor partial agonist, did not delay cardiac repolarization in healthy subjects Loewen, Gordon
2013
9 4S p. P660-P661
artikel
913 Examination of body mass index, organ weights and diagnosed medical conditions in an autopsy series of nondemented individuals and individuals with Alzheimer's disease Dugger, Brittany
2013
9 4S p. P438-P439
artikel
914 Examining the CERAD Memory Performance Index in the Wisconsin Registry for Alzheimer's Prevention Koscik, Rebecca
2013
9 4S p. P610
artikel
915 Exceptional cognitive abilities in the Long Life Family Study (LLFS) Barral, Sandra
2013
9 4S p. P560
artikel
916 Excess costs associated with misdiagnosis of Alzheimer's disease among U.S. Medicare beneficiaries with vascular dementia or Parkinson's disease Kirson, Noam
2013
9 4S p. P845-P846
artikel
917 Exercise ameliorates age-associated hippocampal atrophy in at-risk adults: Evidence from the Wisconsin Registry for Alzheimer's Prevention Jonaitis, Erin
2013
9 4S p. P625
artikel
918 Exercise ameliorates age-associated hippocampal atrophy in at-risk adults: Evidence from the Wisconsin Registry for Alzheimer's Prevention Jonaitis, Erin
2013
9 4S p. P115
artikel
919 Exercise is effective in preventing high-fat-diet–induced beta-amyloid deposition and memory deficit but continuation is necessary to keep the effect of exercise in APP transgenic mice Maesako, Masato
2013
9 4S p. P496
artikel
920 Exercise, TNFα and volume of the aging brain Braskie, Meredith
2013
9 4S p. P398
artikel
921 Exome array analysis identifies novel risk variants for non-familial early-onset Alzheimer’s disease Naj, Adam
2013
9 4S p. P517
artikel
922 Exome sequencing in a novel familial neuronal intermediate filament inclusion disease with unknown genetic defect Chiu, Wan Zheng
2013
9 4S p. P560
artikel
923 Experience with adaptive image-guided radiotherapy (IGRT) at RGCI and RC, India Wadhawan, Gurvinder
2013
9 4S p. P305-P306
artikel
924 Exploratory analyses of regional human brain distribution of the PET tau tracer F18-labeled T807 (AV-1541) in subjects with normal cognitive function or cognitive impairment thought to be due to Alzheimer's disease Mintun, Mark
2013
9 4S p. P842
artikel
925 Exploring associations between serum 25-hydroxyvitamin D and domain-specific cognitive performance using Restricted Cubic Splines: A cross-sectional study in Dutch elderly Brouwer-Brolsma, Elske
2013
9 4S p. P882-P883
artikel
926 Exploring the effects of memantine on the production of beta-amyloid protein species in cells transfected with wild-type and mutant APP linked to familial Alzheimer's disease Tokuda, Takahiko
2013
9 4S p. P182
artikel
927 Exploring the epigenetic architecture of cognitive resilience in aging: A DNA methylation and a genetic scan converge on several loci associated with resilience De Jager, Philip
2013
9 4S p. P829
artikel
928 Exploring the pathogenesis of cognitive impairment in Down syndrome: Genes, mechanisms and treatment targets Mobley, William
2013
9 4S p. P513
artikel
929 Expression of an anti-beta-amyloid catalytic antibody by AAV9-mediated gene delivery effectively prevents and reduces amyloid deposition in an Alzheimer's disease mouse model Kou, Jinghong
2013
9 4S p. P507
artikel
930 Expression of human apolipoprotein E-ε4 reduces uptake and accumulation of docosahexaenoic acid in the brains of mice Dal-Pan, Alexandre
2013
9 4S p. P510
artikel
931 Expression of human mitochondrial transcriptional factor A (hTFAM) improves cognitive function in Alzheimer's disease model mice Oka, Sugako
2013
9 4S p. P548
artikel
932 Expression of the cholesterol ester protein CETP in amyloid precursor protein transgenic mice impacts brain cholesterol and amyloid levels Cramer, Paige
2013
9 4S p. P852
artikel
933 External criteria comparison of global cognition test candidates from the Alzheimer's Disease Neuroimaging Initiative (ADNI) data Crane, Paul
2013
9 4S p. P125
artikel
934 Extracellular versus intracellular anti-tau immunotherapy effects in rTg4510 tau transgenic mice Sahara, Naruhiko
2013
9 4S p. P330-P331
artikel
935 Extracting white matter hyperintensities in Alzheimer's disease risk and aging studies using supervised segmentation methods Ithapu, Vamsi
2013
9 4S p. P99-P100
artikel
936 Extracting white matter hyperintensities in Alzheimer's disease risk and aging studies using supervised segmentation methods Ithapu, Vamsi
2013
9 4S p. P262-P263
artikel
937 Factors associated with frontotemporal lobar degeneration in a memory disorders clinic in Mexico City Mimenza, Alberto
2013
9 4S p. P752
artikel
938 Factors that influence use of plasma beta-amyloid as a biomarker of Alzheimer's disease Rissman, Robert A.
2013
9 4S p. P861-P862
artikel
939 Failure in beta-amyloid degradation in the endosomal/lysosomal pathway results in intracellular beta-amyloid accumulation within lipid rafts Pacheco-Quinto, Javier
2013
9 4S p. P143
artikel
940 Familial neurodegenerative disease with dementia, pyramidal tract signs, hydrocephalus and leukoencephalopathy: Just atypical Alzheimer's disease? Newell, Kathy
2013
9 4S p. P440
artikel
941 Familiar physical activity to familiar music: The effects on apathy, agitation, eating ability, and dietary intake in institutionalized older adults with dementia Moore, Janet
2013
9 4S p. P605
artikel
942 Family-centered strategies to promote cognitive and functional recovery in acutely ill persons with dementia Boltz, Marie
2013
9 4S p. P515-P516
artikel
943 Faster forgetting: Distinguishing Alzheimer's disease and frontotemporal dementia with delayed recall measures Khan, Katija
2013
9 4S p. P526
artikel
944 FDG-PET and PiB-PET imaging in asymptomatic at-risk carriers of a novel octapeptide repeat insertion in PRNP Boeve, Bradley
2013
9 4S p. P585
artikel
945 FDG-PET and PiB-PET imaging in asymptomatic at-risk carriers of a novel octapeptide repeat insertion in PRNP Boeve, Bradley
2013
9 4S p. P52
artikel
946 Feasibility of an RCT on exercise interventions in early-onset dementia: Let's move on! Hooghiemstra, Astrid
2013
9 4S p. P295
artikel
947 Feasibility of evidence-based hand exercises in a home-based program for patients with Alzheimer's disease and depression Bragin, Valentin
2013
9 4S p. P117
artikel
948 [18F] Flutemetamol PET imaging for beta-amyloid deposition across the spectrum of Alzheimer's disease Hatashita, Shizuo
2013
9 4S p. P22
artikel
949 Financial literacy is associated with functional connectivity between anterior and posterior brain regions Han, S. Duke
2013
9 4S p. P198
artikel
950 Financial literacy is associated with functional connectivity between anterior and posterior brain regions Han, S. Duke
2013
9 4S p. P110-P111
artikel
951 First case report: Image to autopsy correlation for tau imaging with [18F]-T808 (AV-680) Kolb, Hartmuth
2013
9 4S p. P844-P845
artikel
952 Fish consumption and exercise in midlife are associated with decreased brain atrophy in women Mortimer, James
2013
9 4S p. P632-P633
artikel
953 Florbetapir F18 PET identification of beta-amyloid in the living brain: A consecutive clinical case series Mitsis, Effie
2013
9 4S p. P373
artikel
954 Florbetapir PET, FDG-PET and MRI in people with Down syndrome with and without symptomatic Alzheimer's disease Sabbagh, Marwan
2013
9 4S p. P290
artikel
955 Florbetapir scanning excludes Alzheimer's disease in a retired NFL player with delayed cognitive impairment Mitsis, Effie
2013
9 4S p. P373
artikel
956 Fluctuations in obstructive sleep apnea severity and cognitive performance in mild Alzheimer's disease Hannesdottir, Kristin
2013
9 4S p. P864
artikel
957 Fluvoxamine attenuates tau phosphorylation through an upregulation of sigma-1 receptors (Sig-1Rs) Omi, Tsubasa
2013
9 4S p. P304
artikel
958 Flux and metabolite pathway mapping in the aging and Alzheimer's disease hippocampus Phelix, Clyde
2013
9 4S p. P346-P347
artikel
959 [18F]NAV4694 shows higher binding and wider dynamic range compared with [11C]PiB in Alzheimer's disease postmortem tissue Zimmer, Eduardo
2013
9 4S p. P584
artikel
960 [18F]NAV4694 shows higher binding and wider dynamic range compared with [11C]PiB in Alzheimer's disease postmortem tissue Zimmer, Eduardo
2013
9 4S p. P22-P23
artikel
961 Focal hemosiderin deposits and beta-amyloid load in the ADNI cohort Kantarci, Kejal
2013
9 4S p. P129-P130
artikel
962 Formal and informal caring of people with dementia: A cohort study in England Gage, Heather
2013
9 4S p. P465
artikel
963 Formation and neurotoxicity of high-mass beta-amyloid assemblies, amylospheroids, from amyloid precursor proteins in neurons with Alzheimer's mutations Komura, Hitomi
2013
9 4S p. P180
artikel
964 Formation of toxic oligomeric species from different proteins in Alzheimer's disease: Potential toxic interactions at the oligomer aggregation stage Guerrero-Munoz, Marcos
2013
9 4S p. P305
artikel
965 Fornix white matter degeneration is a sensitive indicator of both early and late cognitive decline in a diverse community cohort Fletcher, Evan
2013
9 4S p. P601
artikel
966 Fortasyn® Connect enhances synaptic membrane formation and function in the hippocampus of aged rats Cansev, Mehmet
2013
9 4S p. P804
artikel
967 Fractional anisotropy differences in attention and default-mode network areas between healthy aging and Alzheimer's disease Luedke, Angela
2013
9 4S p. P113
artikel
968 Fractional anisotropy differences in attention and default mode network areas between healthy aging and Alzheimer's disease Luedke, Angela
2013
9 4S p. P601-P602
artikel
969 Frailty in relation to late-life cognition: Initial results from the Honolulu-Asian Aging Study Armstrong, Joshua
2013
9 4S p. P611
artikel
970 Frailty in relation to neuropathological markers of Alzheimer's disease: Evidence from a transgenic mouse model Wallace, Lindsay
2013
9 4S p. P500
artikel
971 Frequency and causes of early-onset dementia in a tertiary referral center in Istanbul Topcular, Baris
2013
9 4S p. P737
artikel
972 Frequency of neuropsychiatric symptoms in Hispanics with Alzheimer's disease Salazar, Ricardo
2013
9 4S p. P755
artikel
973 Frontal cortex and normal ageing: A voxel-based morphometry MRI study of healthy individuals Rosa, Pedro
2013
9 4S p. P393
artikel
974 Frontal cortex and normal aging: A voxel-based morphometry MRI study of healthy individuals Rosa, Pedro
2013
9 4S p. P107
artikel
975 Frontal presentations of Alzheimer's disease: A series of people with biological evidence by CSF biomarkers de Souza, Leonardo
2013
9 4S p. P367
artikel
976 Frontemporal dementia mutations in MAPT cause chromosome mis-segregation and aneuploidy including trisomy 21 Potter, Huntington
2013
9 4S p. P193
artikel
977 Frontotemporal dementia associated with the MAPT IVS10+16C>T mutation: A multidisciplinary study Oblak, Adrian
2013
9 4S p. P439-P440
artikel
978 Frontotemporal lobar degeneration: Any link between tau and TDP-43? Buee-Scherrer, Valerie
2013
9 4S p. P438
artikel
979 FTY720/Fingolimod, a sphingosine analogue, reduces beta-amyloid production in neurons Takasugi, Nobumasa
2013
9 4S p. P184
artikel
980 Fully automated quantification of [18F]flutemetamol images used to categorize scans into either normal or abnormal amyloid levels: Sensitivity and specificity against histopathology and concordance with visual read results Thurfjell, Lennart
2013
9 4S p. P407-P408
artikel
981 Functional activities questionnaire items that best predict disease progression in the clinically normal elderly Marshall, Gad
2013
9 4S p. P779
artikel
982 Functional analysis of ABCA7 SNPs, rs3764650 and rs3752246 that strongly associates with the risk of late-onset Alzheimer's disease Bamji-Mirza, Michelle
2013
9 4S p. P853-P854
artikel
983 Functional brain network organization in Alzheimer's disease de Waal, Hanneke
2013
9 4S p. P670
artikel
984 Functional difficulties associated with self-reported confusion or memory loss among adults aged 60 or older - 21 states Deokar, Angela Johnson
2013
9 4S p. P819
artikel
985 Functionality and cognitive performance of patients with behavioral variant frontotemporal dementia Bento da Silva, Thais
2013
9 4S p. P733
artikel
986 Functionally connected networks in mild Alzheimer's disease Weiler, Marina
2013
9 4S p. P407
artikel
987 Functional magnetic resonance imaging changes in subtype amnestic mild cognitive impairment during episodic memory encoding tasks Li, Xin
2013
9 4S p. P413
artikel
988 Functional MRI as a marker of memory network disruption in early Alzheimer's disease Sperling, Reisa
2013
9 4S p. P313
artikel
989 Further evaluation of the indications for the rational use of CSF in the diagnostics of Alzheimer's and related disorders Stokin, Gorazd Bernard
2013
9 4S p. P147
artikel
990 Further exploration of plasma biomarkers for Alzheimer's disease using isotopic tandem mass tags and a combined targeted/nontargeted LC/MS/MS method Lößner, Christopher
2013
9 4S p. P238
artikel
991 Furthering the evolution of the Memory Cafe Chance, Jacquelyn
2013
9 4S p. P76-P77
artikel
992 Future dementia status is almost entirely explained by the baseline and change of the latent variable "d" Palmer, Raymond
2013
9 4S p. P788
artikel
993 Gait ability and cognitive function among older adults with cognitive impairments Doi, Takehiko
2013
9 4S p. P608
artikel
994 Gamma-secretase as a target for Alzheimer's disease therapy: Small-molecule development Augelli-Szafran, Corinne
2013
9 4S p. P811-P812
artikel
995 Gamma-secretase inhibitor (GSI) and modulator (GSM) photoaffinity probes reveal distinct binding sites on presenilin Johnson, Doug
2013
9 4S p. P151
artikel
996 Gamma-secretase trims ε-cleaved products to beta-amyloid 40 and beta-amyloid 42 via two main pathways Fernandez, Marty
2013
9 4S p. P576
artikel
997 Gene-based analyses of microglial activation on [11C] PBR28 PET in older adults at risk for Alzheimer's disease Swaminathan, Shanker
2013
9 4S p. P81
artikel
998 Gene-based analyses of microglial activation on [11C]PBR28 PET in older adults at risk for Alzheimer's disease Swaminathan, Shanker
2013
9 4S p. P255
artikel
999 Genetic ablation of Nrf2 modulates Alzheimer's disease–like pathology in APP/PS1 mouse Joshi, Gururaj
2013
9 4S p. P329
artikel
1000 Genetic algorithm with logistic regression for Alzheimer's disease diagnosis and prognosis Johnson, Piers
2013
9 4S p. P455-P456
artikel
                             2253 gevonden resultaten
 
   volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland